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ABSTRACT 
Na+ -Li+ exchange was proposed as the mode of Na+ -H+ exchange in human body. 7Li 
NMR investigation of Li+ efflux across H+ - and Li+ -loaded RBC ghosts in the presence and 
absence of a pH gradient indicated that Na+ -H+ exchange and Na+ -Li+ exchange competed 
against each other for transport by the same membrane protein when they occurred 
simultaneously. 
Amiloride and its analogues are specific Na+ -H+ exchange inhibitors. Significant 
inhibitory effects of these inhibitors on the kinetic parameters of Na+ -Li+ exchange suggested 
that both Na+-H+ and Na+-Li+ exchange are mediated by the same transport protein. 
Phloretin is an effective Na+ -Li+ exchange inhibitor. Both phloretin and HMA inhibited Li+ 
efflux from Li+ -loaded RBC ghosts. These data also proved that the protein mediating Na+ -
Li+ exchange is the same as the protein mediating Na+-H+ exchange. 
Detailed investigation of the interactions of H+, Lt, and Na+ with RBC membranes 
showed that these three cations bind to the same binding site of the RBC membrane. The 
observation of similar amiloride binding constants to the RBC membranes with Na+ and Li+ 
present indicated that amiloride had the similar inhibitory effects on Na+ and Li+ binding to 
RBC membranes. All of these results suggested that Na+-Li+ exchange and Na+-H+ exchange 
are mediated by the same RBC membrane protein. 
It has been reported that both Na+ -H + and Na+ -Li+ exchange activities were enhanced 
in essential hypertension. In this study we found that Na+ binding to the RBC membranes 
xviii 
from essential hypertensives was weaker than from normotensives. Using 31P NMR, we 
found that the percentage of PS was higher for the hypertensive group than for the 
normotensive group; the percentage of PE was lower for the hypertensive than for the 
normotensive individuals. In intact RBCs, increased kinetic parameters were observed in 
essential hypertension. Therefore we concluded that changes in lipid-protein interactions in 
the RBC membrane of hypertensive patients appear to be responsible for weaker Na+ binding 
to the membrane, and for the faster rates of RBC Na+-Li+ exchange. 
xix 
CHAPTER I 
INTRODUCTION 
1.1. Na+ -H• Exchange in Human Erythrocytes 
Na+ -H+ exchange was first discovered in 1976. Not only because it is an ubiquitous 
transport system, but also because it is involved in a variety of cellular functions, a lot of 
attention has been devoted to the investigation of Na+ -H + exchange (N akhoul and Boron, 
1988). It is a transport system widely distributed in erythrocytes which plays an important 
role in regulating intracellular pH, cellular volume, and transmembrane ion transport 
(Nakhoul and Boron, 1988). Figure 1 shows how Na+ -H+ exchange coupled with chloride-
bicarbonate exchange results in net movement of NaCl into the cell to regulate intracellular 
pH and cell volume (Nakhoul and Boron, 1988). The role of Na+ -H+ exchange in stimulus-
response coupling and cell proliferation is depicted in Figure 2, in which there is a potential 
link between Na+ -H+ exchange, Ca2+ mobilization, and protein kinase C (Rosskopf et al., 
1993). 
The Na+ -H+ exchanger has been found to be an integral membrane protein in all 
eukaryotic cells (Rosskopf et al., 1993). The Na+ -H+ exchanger promotes an electroneutral 
1:1 exchange of intracellular H+ for extracellular Na+ driven by the inwardly-directed Na+ 
gradient established by the Na+/K+ ATPase (Rosskopf et al., 1993). Na+-H+ exchange is one 
of the two independent pathways for passive sodium movement across the vesicle (Wigham 
Figure 1. 
2 
Schematic Diagram of Na• -H • Exchange Coupled with Chloride-bicarbonate 
Exchange to Regulate Intracellular pH and Cell Volume (adapted from 
reference by Nakhoul and Boron, 1988). 
3 
H+~~~~~~~~ H+ 
H20 --t 
co2 ___ C0 2 TOH-
HCO- ~~~-- Hco-3 3 
Figure 2. 
4 
Interaction Between Na+ -H+ Exchange and Ca2+ Mobilization (adapted from 
reference by Rosskopf et al., 1993). 
5 
Ca 2• 
6 
et al., 1994). There are two types of Na+-H+ exchanger which have been reported, one is 
pH-dependent and the other is pH-independent (Kuroda et al., 1994). Na+ -H+ exchange 
removes H+ from the cell in exchange for extracellular Na+. It is activated by the 
transmembrane pH gradient. Internal H+, independent of its role as a substrate for exchange 
with external Na+, has an important modifier role as an allosteric activator of the Na+-H+ 
exchanger. Allosteric behavior with respect to internal H+ is a property that enhances the 
ability of plasma membrane Na+-H+ exchangers to extrude intracellular acid loads and thereby 
contributes to the regulation of intracellular pH (Aronson et al., 1982). The presence of the 
proton activation site has been revealed by investigating the dependence of Na+ -H+ exchange 
activity on internal H+ which is very sigmoidal and has a high Hill coefficient (n = 2-3) 
(Canessa, 1989); Na+-H+ exchange activity greatly increased with an increase of pH in the 
assay medium. pH did not affect the~ value of the Na+-H+ exchange, but did increase the 
V mas value (Kuroda et al., 1994). Sodium has low-affinity single class binding sites on the 
outside of red blood cell (RBC) membranes. The number of Na+ -H+ exchanger sites was 
estimated at 500 per human platelet and 2000 per rat thymocyte (Rosskopf et al., 1993). 
Kinetic studies indicated that amiloride can block 60 to 80 % of H+ -induced Na+ influx 
(Escobales and Canessa, 1986). Further investigations indicated that amiloride strongly 
inhibits the pH-dependent exchanger (Kuroda et al., 1994). The activity of the exchanger 
appears to be modulated by many biological agents, including hormones, growth factors, and 
tumor-promoting agents. Na+ -H+ exchange modes are also regulated by physiological levels 
of insulin (Canessa et al., 1993). 
Molecular biological studies resulted in the cloning of the Na+ -H+ exchanger by genetic 
complementation of mutants lacking Na+ -H+ exchange activity with human genomic DNA. 
Several NHE (Na+-H+ exchange) isoforms have been found. NHE-1 is a 
7 
phosphoglycoprotein of 815 amino acids (Sardet et al., 1989). The gene encoding for NHE-
1 is located on the short arm of chromosome 1 (Dudley et al., 1990; Lifton et al., 1990; 
Mattei et al., 1988), and its structure, including intron-exon organization, has recently been 
determined (Miller et al., 1991). Besides NHE-1, Collins et al. (Collins et al., 1993) have 
cloned a second isoform of the Na+ /H+ exchanger, NHE-2. Recently, the isoform, NHE-
3, bas been cloned. It encoded a protein of 834 amino acids with a calculated relative 
molecular weight of 92,906 (Brant et al., 1995). The putative isoform, NHE-4, has been 
postulated (Rosskopf et al., 1993). 
It was first found in 1952 that the Na+ content in arterial tissue is elevated in essential 
hypertension (Tobian and Binion, 1952). Na+ extrusion systems are very important because 
high intracellular Na+ is unfavorable for the cells. One of the major Na+ extrusion systems 
in Vibrios, the respiratory Na+ pump, only functions under alkaline pH conditions. 
Therefore, another Na ... extrusion system, the Na+ -H+ exchange, must be crucial for the cells, 
especially under neutral pH conditions where the respiratory Na+ pump may not function 
(Kuroda et al., 1994). Na ... -H+ exchange may raise blood pressure by increasing intracellular 
Na+ concentration or pH in renal proximal tubules and vascular smooth muscle (Nakhoul and 
Boron, 1988). It has been found that the increased Na+ -H+ activity in platelets is 
significantly positively correlated with the occurrence of essential hypertension in humans 
(Livne et al., 1987). Na ... -H+ exchange can be up-regulated by salt-sensitive elevation of 
blood pressure (Pontremoli et al., 1992). Recent research suggested that the Na·-H+ 
exchange pathway provides an important new mechanism involved in ischemic/reperfusion 
damage. There is evidence supporting the involvement of Na+ -H+ exchange in reperfusion 
(Pierce and Meng, 1992). Increased Na+ -H+ exchange activity can occur by an increase in 
the number of transport sites or by an increased turnover induced by increased 
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phosphorylation activated by cytosolic Ca2+ and protein kinases A and C (Canessa et al., 
1993). The maximal rate of Na+ -H+ exchange is related to the fluidity of the membrane and 
serum cholesterol (Carr et al., 1993). 
Because the RBC membrane transport protein is asymmetric with higher ionic affinities 
on the intracellular side of the membrane than on the extracellular side (Hannaert and Garay, 
1986; Sarkadi et al., 1978), and because the affinities of H+ and Na+ to RBC membranes are 
highly asymmetric (H+ > Na+), the outside membrane is not saturated by Na+ during the 
process of Na+ -H+ exchange. The rate measured by the standard method (Canessa, 1989) 
is not the maximal rate. Na+-H+ exchange follows first order kinetics (Carr et al., 1993). 
The rate constant, as a characteristic of an ion transport system, is expressed in the following 
way: 
(1) 
where v is the flux rate of the metal ion M+, [M+] is the external M+ concentration in the 
influx transport process or the internal concentration in the efflux transport experiments. 
Replaced by the Michaelis-Menten equation, equation (1) can be changed to equation (2): 
(2) 
where V max is the real maximal rate, and K,,, is dissociation constant of the metal ion M+ to 
the RBC membranes. In the case of Na+-H+ exchange, the kinetic parameters can also be 
analyzed by the following equation (Carr et al., 1993): 
[Na+]/(rate of pH change)= (K,,, + [Na+])/V111u (3) 
1.2. Na+-Li+ Countertransport in Human Erythrocytes 
There is no lithium in the human body. After Cade first successfully introduced lithium 
in the treatment of mania in 1949 (Cade, 1949), many studies have aimed to investigate 
9 
lithium transport in the human body. There are five lithium transport pathways in human 
RBCs (Figure 3): Na+ -Lt countertransport, K+ -Lt -Cr cotransport, anion exchange, the Na+, 
K+-ATPase, and a residual Li+ pathway (Duhm, 1992). Because of its high reproducibility, 
Na+ -Li+ countertransport has been studied in the human population in more detail than any 
other ion transport mechanism. It was found that Na+ -Li+ countertransport is sensitive to pH 
and temperature (Rutherford et al, 1992a). It can be inhibited by phloretin (Pandey, et al., 
1978). Inhibitin has recently been reported as a specific inhibitor of Na+ -Na+ and Na+ -Li+ 
exchange (Morgan et al. , 1989). 
Dorus et al. (Dorus et al., 1983) have found evidence for an autosomal major gene locus 
encoding a polypeptide chain of a RBC membrane protein responsible for Na+ -Li+ exchange 
for which a polymorphism occurred. There are strong positive correlations between Na+ -
Li+ countertransport and polygenes or a major gene (Williams et al., 1988); the variation in 
Na+-Li+ countertransport was explained 34.4% by a major locus and 45.9% by polygenic 
inheritance giving a total of 80. 3 % due to genetic factors (Hasstedt et al., 1988). Studies on 
Na+ -Li+ countertransport and on the family history of hypertension indicated that Na+ -Li+ 
countertransport can be a marker of the genetic predisposition to primary hypertension in 
childhood (Houtman et al., 1993). 
In 1980, Canessa et al. (Canessa et al., 1980a) first reported that Na+ -Li+ 
countertransport was greater in patients with essential hypertension than in normotensive 
individuals. High mean levels of Na+ -Li+ countertransport have been found consistently in 
essential hypertensives compared with normotensive individuals by many groups all over the 
world (Motulsky et al., 1987). The abnormal Na+-Li+ exchange activity has also been found 
in other diseases such as hyperlipidemia and diabetes, and it has also been reported for 
women taking oral contraceptives and in late pregnancy (Rutherford et al., 1992a). Blacks 
Figure 3. 
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Li+ Transport Pathways in Human RBC (adapted from reference by Mota 
de Freitas et al., 1991). 
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generally have lower values of Na· -Li+ countertransport than whites; elevated 
countertransport is, however, a characteristic in most black hypertensives (Weder, 1993). 
A positive association between Na+ -Li+ countertransport and blood pressure has been found 
(Turner et al., 1985). It was reported that a person with a high countertransport value was 
1.3-1.9 times more likely to develop hypertension than a person with a low value (Laurenzi 
and Trevisan, 1989). Subjects with an elevated maximal activity for RBC Na+ -Li+ 
countertransport are a subset of the population with a genetic lesion that predisposes them to 
the development of essential hypertension (Weder et al., 1991). Increased RBC Na+ -Li+ can 
be considered as a possible intermediate phenotype for hypertension (Weder, 1993). Na+ -
u+ countertransport has been used to classify essential hypertensives in clinical examination 
(de al Sierra et al., 1993). 
Prior to 1990, the maximal rates of Na+ -Lt exchange in human RBCs were generally 
assayed by measuring the rates of Li+ efflux from u+-loaded RBCs into Na+-containing and 
Na+-free media; the maximal rates of RBC Na+-Lt exchange were then calculated by 
subtraction of the measured rates of Li+ transport in the Na+ -free medium from those 
measured in the Na+ -containing medium (Canessa et al., 1980a). It was recently found that, 
under the standard transport assay conditions, Li+ is present at a saturating concentration, but 
Na+ may not be (Rutherford et al., 1990; Rutherford et al., 1992a). The dissociation 
constants CK...) for extracellular Na+ are, for at least some individuals, of the same order of 
magnitude as the extracellular Na+ concentration (140 mM) used in the standard transport 
assay, suggesting that the RBC Na+-Li+ exchange protein is far from saturated with Na+ on 
the extracellular side of the RBC membrane. The rates obtained by using the standard 
transport assay conditions may not therefore be maximal rates of RBC Na+ -Li+ exchange; 
variations in Na+ affinity (K,,,) and maximal velocity (V maJ could change the observed rates. 
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Only by varying the Na+ concentration in an isotonic suspension medium, can one measure 
the true kinetic parameters of RBC Na+ -Li+ exchange with equation (2) (Hannaert and Garay, 
1986; Rutherford et al., 1990; Rutherford et al., 1992a). 
Both RBC Na+ -H+ and Na+ -Li+ exchangers are elevated in essential hypertensive 
patients relative to normotensive individuals (Semplicini et al., 1989). Na+ -Li+ 
countertransport is readily observable in human RBC (Canessa et al., 1987; Semplicini et al., 
1989), and it is also considered that in the red cell, an enhanced Na+ -Li+ countertransport 
rate is the best reproducible finding among the Na+ transport systems in primary hypertension 
(Hilton, 1986). It has been proposed that RBC Na+ /Li+ exchange may be a mode of 
operation of Na+ /H+ exchange (Canessa et al., 1988). Recent genetic studies also proposed 
hypotheses that Na+ -H+ is highly regulated by insulin levels therefore potentially connecting 
the genetics of Na+ -Li+ countertransport to hyperinsulinemia and "dyslipidemic hypertension" 
(Williams et al., 1994). But whether or not Na+ -H+ and Na+ -Li+ exchange are mediated by 
the same membrane protein is still unknown. 
1.3. Na+-H+ and Na+ -Li+ Exchange Inhibitors 
Amiloride is a specific inhibitor of Na+ -H+ exchange systems. The inhibitory activities 
of amiloride and its analogues have been used to characterize the Na+ -H+ exchanger. 
Amiloride is a weak base (pK. = 8. 7) (Kleyman and Cragoe, 1988). The structure of 
amiloride is shown in Figure 4. It is a pH-dependent inhibitor because only its protonated 
form can interact with Na· channels (Kleyman and Cragoe, 1988). It can block 60-80% of 
the H+ -induced Na+ entry and has small effects in the absence of pH gradients (Dubinsky and 
Frizzell, 1983; Escobales and Canessa, 1986). The protonated form of amiloride can enter 
cells and exert additional effects (Benos et al., 1983). A high concentration (0.1-1 mM) of 
Figure 4. 
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Structures of Amiloride, 5-(N,N-hexamethylene)-amiloride (HMA), 5-(N-
ethyl-N-isopropy 1)-amiloride (EIP A), and 5-(N-methy 1-N-isobutyl)-amiloride 
(MIA). 
0 
II NH2 c1JCNXc, I I = N=C-NH2 0 N NH, 
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amiloride is required to inhibit Na+ -H+ exchangers (Dubinsky and Frizzell, 1983). Many 
amiloride analogues such as 5-(N ,N-hexamethylene)-amiloride (HMA), 5-(N-ethyl-N-
isopropyl)-amiloride (EIPA) and 5-(N-methyl-N-isobutyl)-amiloride (MIA) (structures are 
shown in Figure 4) have been found to be 100-1000-fold more potent than amiloride 
(Kleyman and Cragoe, 1988). Studies on structure-activity relationships of amiloride 
analogues indicated that the guanidinium moiety of amiloride is the active group that 
recognizes and binds to the Na+ transport site of the exchanger (Simchowitz and Cragoe, 
1986). Replacements in the 6-Cl position reduced the inhibitory activity (Simchowitz and 
Cragoe, 1986). Increasing the number of carbon atoms in the alkyl chain increased the 
activity, and branched alkyl groups were more effective than straight chains (Simchowitz and 
Cragoe, 1986). The lipid concentration present in the experiments critically determined the 
inhibitory concentrations, because the inhibition activity increased with a decrease in lipid 
concentration (Davies and Solioz, 1992). Molecular studies on the topology of the amiloride 
binding site showed that the amiloride binding site on proteins appear to be a pocket formed 
by planar aromatic amino residues, including tyrosine, phenylalanine, and histidine into which 
amiloride, a large planar molecule, inserts (Lin et al., 1994). 
Phloretin (shown in Figure 5), a dianionic-type organic compound, strongly inhibits Na+ -
dependent Li+ efflux (Pandey et al., 1978). Due to its dianionic characteristics, phloretin 
affects the voltage-dependent ion conductance. It blocks the ion channel more strongly at 
negative membrane potentials than at positive membrane potentials (Klusemann and Meves, 
1992). Although it also affects potassium channels, phloretin is still an effective Na+ -Li+ 
inhibitor. Other studies have shown that phloretin is a specific glucose transport inhibitor 
which has been used to inhibit tumor cell growth (Nelson and Falk, 1993 a and b). Phloretin 
is also considered a competitive inhibitor (Nelson and Falk, 1993 b). 
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Figure 5. Structure of Phloretin. 
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The effects of both amiloride and phloretin on both Na+ -H+ exchange and Na+ -Li+ 
countertransport have been tested by the standard assay. It was found that amiloride and its 
analogues, HMA and EIPA, decreased RBC Na+-H+ exchange (Escobales and Canessa, 1985; 
Escobales and Canessa, 1986; Kleyman and Cragoe, 1988), but not RBC Na+-u+ exchange 
(Pandey et al., 1978); phloretin inhibits human RBC Na+-u+ exchange, but not RBC Na+-
H+ exchange (Pandey et al., 1978). However, amiloride inhibits both Na+-H+ and Na+-u+ 
exchange in bovine vascular smooth muscle (Kahn et al., 1989). It is possible that amiloride 
and its analogues change the kinetic parameters V max or K,,, but do not change V stsJ for RBC 
Na+-u+ exchange. To test the inhibitory activity of amiloride and its analogues on Na+-
u+ exchange across intact RBCs, we propose to address whether or not Na+ -H+ and Na+ -
Li+ are mediated by the same membrane protein. 
1.4. RBCs and RBC Ghosts 
Whole human blood contains plasma and erythrocytes. The sodium, potassium, 
magnesium, and calcium concentrations in the plasma are 138, 4.0, 0.86, and 2.0 mM, 
whereas the concentrations of those ions in erythrocytes are 10, 88, 2.5, and 4.6 mM (Touyz 
et al., 1992). Erythrocytes are separated from plasma by red blood cell membranes. The 
human erythrocyte membrane is composed of 49% protein, 43% lipid and 8% carbohydrate. 
For lipid, 32 % is phospholipid and 11 % is cholesterol. The main phospholipid components 
are phosphatidyl choline (PC), phosphatidyl ethanolamine (PE), phosphatidyl serine (PS), 
phosphatidyl inositol (Pl), and sphingomyelin (Sph). The head groups of the phospholipids 
PI and PS are negatively charged, and these two anionic phospholipids reside primarily in the 
inner leaflet of the RBC membrane. PC, PE, and Sph are neutral. PC and Sph are 
predominantly present in the outer leaflet, whereas PE is predominantly restricted to the inner 
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leaflet. 
Na+-u+ countertransport activity is mediated by an RBC membrane protein (Motulsky 
et al., 1987), and so is Na+-H+ exchange. Measurements of Na+ or Li+ movements across 
resealed ghosts, instead of through intact RBCs, simplify the study of RBC transport proteins, 
because resealed RBC ghosts are post-hemolytic residues of RBCs which are devoid of 
intracellular structure and contain primarily cell membranes (Schowch and Passow, 1973). 
Ghosts are ideal models to study ion transport without the interferences of hemoglobin and 
other factors existing inside the red blood cells. Ghosts have the advantage over intact RBCs 
of being amenable to be loaded with the required concentrations of ions for the measurements 
of ion exchange, and they have been used successfully to study lithium transport (Duhm et 
al., 1976). 
There are two kinds of hypotonic ghosts that have been made: white ghosts, and resealed 
ghosts (as shown in Figure 6). The value of resealed ghosts to characterize transport 
properties of the RBC membrane is that resealed erythrocyte ghosts can maintain most of the 
characteristics of the native erythrocyte membranes (Klonk and Deuticke, 1992), and that they 
can recover their permeabilities to metal ions such as u+, Na+ and K+ (Hoffman, 1992). 
The permeability of resealed ghosts to hemoglobin and small ions during hemolysis and 
resealing depends on the conditions at and after hemolysis such as temperature, pH, and ionic 
strength (Hoffman, 1992). The purity of the resealed ghosts is generally assumed to be 
related to the retention of hemoglobin, which in tum depends on the conditions during 
hemolysis and resealing. The number of holes through which hemoglobin can escape during 
hemolysis can range from one to many (Hoffman, 1992). For ghosts in which only one hole 
was seen, the size of the hole ranged from below 100 A to 1 µm or more (Hoffman, 1992). 
The permeability of membrane to hemoglobin is determined by the number of holes, the size 
Figure 6. 
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Electron Micrograph of An Erythrocyte Ghost (adapted from reference by 
Mathews and van Holde, 1990). 
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of the holes, and the opening time of the holes (Hoffman, 1992). There are many factors 
controlling the yield of resealed ghosts, such as temperature, pH, ionic strength. and the 
presence of alkali metal ions (Bodemann and Passow, 1972). 
Ionic movements through RBCs are mainly related to the fluidity of the membrane and 
the interactions between ions and membrane proteins and phospholipids. The interactions 
between ions and membranes can be addressed by testing the amounts of free and bound ions 
in RBC membrane suspensions. Exposure of white ghosts (exposed RBC membrane) to ions 
makes it possible to directly test these interactions. The composition and the function of the 
RBC membranes are demonstrated by membrane constituency, activity of enzymes, 
organization of the membrane constituents, permeability, etc. It is generally agreed that there 
is no measurable loss of cholesterol or phospholipid from the membrane during the 
preparation of white ghosts (Schwoch and Passow, 1973), but considerable structural changes 
occur in the lipids. The loss of membrane proteins depends on ionic strength and pH, and 
the release of all membrane proteins is not equal. White ghosts still contain a large number 
of enzymes, even though some loosely bound enzymes are lost in the preparation. The loss 
of enzymes is also affected by osmolarity and pH (Schwoch and Passow, 1973). 
1.5. Essential Hypertension 
Hypertension is a physiological phenomenon, and high blood pressure is considered to 
be an important risk factor in stroke, and in heart and renal disease (Motulsky et al, 1987). 
Essential hypertensive patients have only high blood pressure (diastolic pressure equal or 
higher than 90 mm Hg) but do not suffer from hypothyroidism, diabetes mellitus, 
hyperlipidemia, obesity, pregnancy, or other conditions which could affect blood pressure. 
Essential hypertension is one subgroup of hypertension in which genetic factors are deemed 
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to play an important role in its development (Saruta, 1994). Studies on familial aggregation 
of blood pressure, twin studies, population-based family studies, and adoption studies are 
concordant, and indicated that 20% to 40% of the population variance in blood pressure is 
generally genetically determined (Lifton, 1993). Two genetic loci promoting human 
hypertension have been well established. One is the GRA (glucocorticoid-remediable 
aldosteronism), a rare "determinant" gene which seems to produce severe hypertension and 
early strokes; the other is AGT (angiotensinogen), a very common "susceptibility" gene which 
seems to predispose patients to hypertension but may need other genetic and environmental 
influences to be fully expressed (Williams et al., 1994). The role of AGT as a molecular 
basis of human hypertension is well described (Jeunemaitre et al., 1992). 
As previously mentioned, essential hypertensive patients have elevated Na+-H+ and Na+-
u+ exchange activities. The Na+-H+ as well as the Na+-u+ exchanger genes are used as the 
best-characterized cause and intermediate phenotypes in the linkage studies for the 
investigation of genetic factors in essential hypertension (Lifton, 1993). In vitro, the rate of 
RBC Na+ -Li+ is one possible marker of essential hypertension which is supported by parent-
offspring and sib-sib correlations > 0.3 and by nonsignificant spouse correlations (Hasstedt 
et al., 1988). Na+ -Li+ exchange rates have been used to investigate abnormalities in RBCs 
from essential hypertensive patients (Canessa et al., 1980a). The abnormal Na+ -Lt 
countertransport activity may be caused by an increase in the number of countertransporters, 
by structural changes in the transport protein, or by changes in the phospholipid environment 
around the transport protein. Changes in the number of countertransporters and in the 
transport protein structure are controlled by genetic factors. Changes in the transporter 
protein structure and the phospholipid environment can also result in the different affinities 
of Na+ or u+ to the RBC membranes of hypertensive patients. Significantly lower Na+ 
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binding constants to exposed RBC membranes in essential hypertensive patients have been 
reported (Ong and Cheung, 1986; Urry et al. , 1980). However, no information about Li• 
interactions with RBC membranes was reported prior to our investigation. Phospholipid 
compositions extracted from RBC membranes of essential hypertensive patients were 
measured by two-dimensional thin-layer chromatography, 20-TLC (Preiss et al., 1982). No 
significant differences were found by the 2D-TLC method between hypertensive patients and 
normal individuals. The amounts of PS and PI were, however, not separately reported in that 
study, and the saturated phospholipid compositions could not be detected by the 2D-TLC 
method. It is therefore possible that abnormal phospholipid compositions exist in essential 
hypertension that have gone undetected by the analytical methods previously used. Higher 
PC/Sph ratios and abnormal molecular species in PC and PE that correlated with enhanced 
Na•-u• activity were found in hyperlipidemic patients (Engelmann et al., 1992 a; Engelmann 
et al., 1992 b; Engelmann et al., 1993). Alterations of the fatty acid composition of some 
phospholipids in essential hypertensive patients have been found to cause abnormal RBC Na+ -
u• exchange activity (Engelmann and Duhm, 1991; Engelmann et al., 1993; Ollerenshaw 
et al., 1987). 
Normal erythrocytes contain 2.5 mM Mg2+, which is essential for the use of ATP and 
other metabolic processes. Intracellular Mg2• ions exist in two forms: as free Mg2•, and as 
a Mg2+ -ATP complex which serves as a donor of high-energy phosphate (Bock et al., 1985). 
Free Mg2• is known to regulate the activity of various enzymes involved in macromolecular 
synthesis, glycolysis, respiration, and in RBC membrane transport processes (Ramasamy and 
Mota de Freitas, 1989). It has been reported that untreated essential hypertensive patients 
had lower intracellular free magnesium (192 ± 8 µM) than normal controls (261 ± 9.8 µM), 
whereas medication-treated essential hypertensives had increased intracellular magnesium (237 
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± 7.8 µ.M) (Resnick et al., 1984). Ca2+ is responsible for vascular smooth muscle 
contractility and peripheral resistance. Lower free intracellular magnesium levels may lead 
to an increased intracellular Ca2+ concentration which induces high blood pressure. In this 
dissertation, I investigate whether the lower free intracellular magnesium levels in RBCs from 
essential hypertensive patients were related to other abnormalities associated with essential 
hypertension such as Na+ -Li+ countertransport activity, Na+ and Li+ interactions with RBC 
membranes, and phospholipid composition in RBC membranes. 
1.6. Techniques 
Several methods such as atomic absorption (Canessa, 1989), fluorescence (Carr et al., 
1993), and flame photometry (Nissen et al., 1989) have been used to measure Na+ -Li+ and 
Na+ -H + exchange activities. The atomic absorption method has been used most frequently, 
because of its high selectivity and sensitivity, and of its simplicity. Each element absorbs 
radiation at a specific wavelength and it is not prone to interference. Very small amounts of 
ions in biological systems can be detected. Reproducible results have been obtained for the 
analysis of Na+-u+ exchange, but it is difficult to obtain reproducible results for Na+-H+ 
exchange by the atomic absorption method, because it is difficult to obtain intracellular Na+ 
concentrations completely separated from extracellular Na+ (Canessa, 1989). The atomic 
absorption method requires physical separation of intra- and extracellular ions by 
centrifugation and cell lysing. It is possible to induce errors by the invasive nature of this 
method because of nonspecific ion binding to membranes and cell metabolites, and additional 
ion transport during sample processing (Mota de Freitas et al., 1991). 
Nuclear magnetic resonance (NMR) spectroscopy provides a non-invasive method to 
monitor ion transport in biological systems, because it can simultaneously visualize the intra-
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and extracellular ion pools during the ion transport process without lysing the RBCs. Shift 
reagents (SRs) make it possible to clearly separate intra- and extracellular signals. Shift 
reagents, discovered by Hinckley in 1969 (Hinckley, 1969), give shifts without significant line 
broadening (Friebolin, 1993). Negatively-charged shift reagents are soluble in aqueous 
solution but are insoluble in hydrophobic solutions. Due to the hydrophobic nature of cell 
membranes, SRs are not soluble in RBC membranes; in addition, they are repelled by the 
negatively charged head groups of phospholipids. SRs remain in the extracellular 
compartment during NMR experiments and produce a large hyperfine shift for the 
extracellular Na+ or Li+ ions because lanthanide SRs are paramagnetic and the extracellular 
ions are subject to a pseudocontact shift. Thus intracellular and extracellular signals are 
effectively separated. The most popular lanthanide shift reagents are Dy(TTHA}3-, 
Tm(DOTP)s- and Dy(PPP)/- (Mota de Freitas, 1993). Dy(TTHAt and Tm(DOTP)s- induce 
downfield shifts whereas Dy(PPP)/- induces an upfield shift. The opposite direction of the 
pseudocontact shifts induced by Dy(TTHA)3° or Tm(DOTP)s- and by Dy(PPP)/° for Na ... and 
Li+ are due to the different locations of the Na ... and Li ... relative to the cones around the 
effective magnetic axes of these SRs. SRs have been successfully used to discriminate intra-
and extracellular Na+ and Li ... signals (Gupta and Gupta, 1982; Mota de Freitas et al., 1990). 
Besides the SR method, the Modified Inversion Recovery (MIR) method can be used to 
resolve intra- and extracellular resonances (Mota de Freitas, 1993). Based on the 
transmembrane difference in the T 1 values the modified inversion recovery pulse sequence, 
(01-180°-02-60°-AQ)n, is applied to eliminate the extracellular alkali NMR resonance and 
selectively observe the intracellular NMR resonance (Mota de Freitas, 1990; Mota de Freitas, 
1993). 
Visibility of intracellular alkali metal NMR resonances is a matter of concern, because 
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it may be less than 100% for some nuclei (Mota de Freitas, 1993). It has been shown that 
lithium is 100% visible in NMR experiments of RBC suspensions by comparing the 
measurements of intracellular lithium concentrations by using both atomic absorption and 
NMR methods (Mota de Freitas et al., 1990). The visibility of intracellular Na+ by NMR 
is, however, only 75% (Nissen et al., 1989). The NMR-invisible intracellular Na+ ions may 
interact strongly with negatively charged phospholipids on the cytoplasmic side of the 
erythrocyte membrane. A subpool of intracellular Na+ experiences large enough quadrupolar 
broadening to cause the disappearance of the corresponding resonance, whereas intracellular 
Li+ does not lead to partial NMR invisibility presumably because of the small quadrupolar 
broadening experienced by Li+ (Mota de Freitas et al., 1990). Another possible reason for 
the different visibility properties of Li+ and Na+ resonances is that the binding sites of Li+ 
and Na+ to RBC membranes are different (Nissen et al., 1989). 
Measurements of ionic movements across resealed RBC ghosts can also be obtained by 
the SR method as for intact RBCs. 
lip NMR has been used successfully to measure free intracellular Mg2+ without 
destroying RBCs (Bock et al., 1985). Well-defined aP, /3P and -yP resonances of ATP are 
present in lip NMR spectra of RBCs. The relative chemical shifts of the l•p resonances of 
erythrocyte ATP are predominantly determined by the interactions between magnesium and 
ATP. 
NMR is considered to be a sensitive and powerful technique for the study of molecular 
dynamics in biological systems. There are two states in which ions can exist in biological 
systems, in free motion or in slow motion. NMR relaxation measurements, in particular, 
provide information about molecular motions. In relaxation methods, the (180° - T - 90°) 
pulse sequence is the most commonly used sequence to accurately measure T 1 (longitudinal 
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relaxation time) (Urry et al., 1989). The properties of the nucleus, the surrounding lattice, 
and the interactions between the two determine the relaxation mechanism. Correlation time, 
re, is a parameter that is used to describe molecular motion. For the extreme narrowing 
condition «~lrc2 ~ 1), the spin-lattice (l/T1) and spin-spin (l/T J relaxation rates are equal 
and undergo a single exponential decay expressed by equation (4): 
l/T1 = l/T2 = 3(21 +3)x2rj40I2(2I - 1) (4) 
where x is the product of the quadrupolar coupling constant, e2qQ/h, and the asymmetry 
factor, 1 + 1113 (eq is the electric field gradient, eQ is the electric quadrupole moment, h 
is the Plank's constant, and T/ is fractional enhancement in NOE). In a homogeneous 
magnetic field, the reciprocal of T2 is proportional to the line width at half-intensity of the 
signal, Avw and is written as 
l/T2 = 7rAv112 (5) 
The nuclear spin quantum number for both 23Na and 7Li is 3/2; both nuclei have finite 
quadrupole moments. The relaxation and exchange times in the bound state are much shorter 
than those in the free state, and the relaxation decay is biexponential (Mota de Freitas, 1993). 
For I = 3/2 nuclides and for two-site exchange when one site (the hydrated ion in aqueous 
solution) is under the extreme narrowing condition and the other site (a membranous peptide 
binding site) is not, the time dependencies of the longitudinal, Mz(t), and transverse, Mit), 
magnetizations can be expressed by equations (6) and (7), respectively (Detelier, 1987; 
Harris, 1983; Urry et al. , 1989): 
Mz(t) = Mz(0)[0.2exp(-t/T1) + 0.8exp(-t/T1)] 
MT(t) = MT(0)[0.6exp(-t/T2) + 0.4exp(-t/T2°)] 
(6) 
(7) 
where the single and double primed symbols denote the relaxation times for the two 
components. With Pi,, the mole fraction of bound ions being very small compared to Pr, the 
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mole fraction of free ions in solution, T 1', T1·, T1', and T1' can be given by the following 
equations: 
1/T,· = l/Tu + [p,,x2/10][r/(l + w2r2)] 
l/T,· = l/T1, + [p,,x2110][rj(l + 4w2r 2)] 
l/T2' = llTu + [p,,x1r/20][1 + 1/(1 + w2r2)] 
l!T2° = l/Tlf + [p,,x2rj20][1/(1 + 4w2r2) + 1/(1 + w2r2)) 
where f and b subscripts refer to free and bound states. 
(8) 
(9) 
(10) 
(11) 
In the extreme narrowing condition, a Lorentzian lineshape which is characterized by 
a Av11/ Av112 ratio of 7111 is observed. But in most biological samples a non-Lorentzian line 
shape is observed, which is resolved into a narrow Lorentzian curve, due to the slow 
relaxation component and accounting for 40% of the total signal intensity, and a broad 
Lorentzian curve, originating from the fast relaxation component and responsible for the 
remaining 60% of the total signal intensity (Mota de Freitas, 1993). There are two methods 
for determining relaxation time constants, one is curve resolution with l/T2 = 11"Av1,1 , and the 
other is the null method (Urry et al. , 1989). 
Phospholipid compositions in RBC membranes have been previously analyzed by two-
dimensional thin-layer chromatography (Preiss et al., 1982; Sengupta et al., 1981) or high-
performance liquid chromatography (Kurumi et al., 1991). The visualization reagents used 
in thin-layer chromatography or the ultraviolet absorbance measurements used in high-
performance liquid chromatography (HPLC) result in detection of only unsaturated fatty acids 
by these methods (Pearce et al., 1991; Spillman et al., 1983). High-resolution 31P NMR was 
introduced by Meneses and Glonek (Meneses and Glonek, 1988) to measure phospholipid 
compositions of cell membranes. The 31P NMR method has the advantage of being sensitive 
to total, and not just unsaturated, phospholipid. After improving the composition of the 
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solvent system used for dissolving the phospholipid extracts (Edzes et al., 1992), very good 
resolution for phospholipid extract samples has been achieved by 31P NMR. 
CHAPTER II 
STATEMENT OF THE PROBLEMS 
The purpose of this thesis is to investigate whether or not Na+ -H+ and Na+ -Li+ 
exchange are mediated by the same RBC membrane transport protein, and to address the 
correlations of Na+-Li+ exchange activity with Na+ and Li+ binding to RBC membranes and 
their phospholipid compositions, as well as with total phospholipid concentrations, and 
intracellular free Mg2+ concentrations in RBCs from essential hypertensive patients and 
normotensive individuals. 
Na+-H+ exchange occurs in the human body. It is very important in regulating 
intracellular pH, cellular volume, and transmembrane ion transport (Nakhoul and Boron, 
1988). Na+ _Li+ exchange is observable in human RBCs, and has been considered as the most 
reproducible Na+ transport pathway in primary hypertension (Hilton, 1986). Na+ -Li+ 
exchange has been used as a marker of genetic predisposition to primary hypertension in 
childhood (Houtman et al., 1993). Both RBC Na+-H+ and Na+-Li+ exchange rates are higher 
for hypertensives than for normotensives (Semplcini et al., 1989b), and both Na+-H+ and 
Na+ -Li+ exchanger genes have been used as the most characterized cause and intermediate 
phenotypes in the linkage studies for the investigation of genetic factors in essential 
hypertension (Lifton, 1993). Na+-H+ exchange and Na+-Li+ countertransport were 
significantly positively correlated in RBCs from hypertensive patients with insulin-dependent 
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diabetes mellitus (Semplicini et al., 1989a). It was reported that Na+ -H+ exchange may 
potentially connect the genetics of Na+ -Li+ countertransport to hyperinsulinemia and 
"dyslipidemic hypertension" (Williams et al., 1994). H, Li, and Na are in the same group 
in the periodic table, and they are the only substrates for most of the monovalent cation 
transport system (Jennings et al., 1985). But whether or not these two ionic exchange 
processes are mediated by the same membrane transport protein is still unknown. 
Amiloride and its analogues, HMA, EIPA, and MIA, are specific Na+ -H+ exchange 
inhibitors, whereas phloretin is a very effective Na+ -Li+ exchange inhibitor. Na+ -H+ and 
Na+ -Li+ exchange are mediated by the same transport system in sarcolemmal vesicles from 
bovine superior mesenteric artery, because both Na+-H+ and Na+ -Li+ exchange in 
sarcolemmal vesicles were inhibited by EIPA (Kahn et al., 1989). However a difference was 
found between Na+ -H+ exchange and Na+-u+ countertransport in human RBCs, because Na+-
u+ countertransport was not inhibited by amiloride (Kahn, 1987). Inhibitors were therefore 
previously used to address whether or not Na+ -H+ and Na+ -Li+ exchange were mediated by 
the same RBC transport system. The inhibitory activities of the inhibitors were, however, 
tested by measuring the standard rates of RBC Na+-H+ or Na+-Li+ exchange under the 
standard assay conditions (Canessa et al., 1980a; Canessa et al., 1992; Kahn, 1987; Kahn, 
1989). In the standard assay conditions, the extracellular side of the RBC membranes were, 
however, far from saturated with Na+ (Canessa et al., 1992; Rutherford et al., 1990; 
Rutherford et al., 1992a). It is possible that the transport inhibitors change V mu and ~ but 
do not change V su1· In this study the transport inhibitors were used to test their effects on all 
of the kinetic parameters of RBC Na+-u+ exchange. 
Na+ -H+ and Na+ -Li+ exchange are operational in membranes present in intact RBCs. 
Resealed RBC ghosts are devoid of hemoglobin and of other factors, and still maintain most 
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transport characteristics of the native erythrocyte membranes (Klonk and Deuticke, 1992). 
They can be loaded with the required concentrations of ions. They are ideal models to 
investigate ion transport without the interference of hemoglobin and of other factors. To test 
whether or not there is competition between Na+-Li'" and Na•-H+ exchange when they occur 
simultaneously is another way to address this question. Comparison of Li• efflux rates across 
u• -loaded resealed RBC ghosts induced by an outside Na• gradient in the absence of a pH 
gradient with the rates in the presence of a pH gradient will tell us whether or not Li• and 
H+ interact with the same membrane transport protein; furthermore these studies will tell us 
whether or not Na+ -H• and Na• -Li• exchange compete against each other. Both Na+-H+ and 
Na+-u+ exchange inhibitors, HMA and phloretin, will be applied to the u• efflux rate 
measurements to investigate their inhibitory effects. 
The rate of ion transport depends on the interactions between ions and the RBC 
membranes. To fully address the interactions in detail, the inhibitory activities of amiloride 
will be investigated by testing the inhibitory binding constants to RBC membranes for both 
Na• and u• binding to RBC membranes. The same inhibitory binding constants of amiloride 
for both Na• and u• at the same pH would indicate that RBC Na• -H• and Na• -Li+ exchange 
are mediated by the same RBC membrane transport protein. 
Atomic absorption methods will be used to measure Na ... -Li• exchange kinetic 
parameters. 7Li NMR will be applied to measure Na•-induced u· efflux rates across u• -
loaded resealed RBC ghosts in the absence and in the presence of a pH gradient with and 
without transport inhibitors. The inhibitory binding constants of amiloride will be generated 
by James-Noggle plots from 23Na T1 and 
7Li T 1 relaxation measurements. 
As mentioned before, RBC Na• -Li• exchange rates are higher for essential hypertensive 
patients than for normotensive individuals (Canessa et al., 1980a). There are several reasons 
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which can cause the abnormal Na+ -Li+ exchange activity in essential hypertension: changes 
in the number of countertransporter molecules; changes in the transport protein structure; and 
the abnormal phospholipid environments around the transporter. Hyperlipidemia generally 
occurs along with hypertension, and the medications used for lowering lipid are suggested for 
use in hypertension. Therefore the abnormal phospholipid environments around the transport 
protein are considered to be the most important reasons for causing the abnormal Na+ -Li+ 
exchange activity in essential hypertension. The affinities of Na+ and Li+ to RBC membranes 
may be directly related to the Na+ -Li+ exchange rates. The probable abnormal phospholipid 
compositions may affect the affinities of Na+ and Li+ to RBC membranes. It was also found 
that essential hypertensive patients have lower intracellular free Mg2+ concentrations than 
normal individuals (Gupta and Gupta, 1987; Resnick et al., 1984). 
The kinetic parameters of RBC Na+ -Li+ exchange will be measured by atomic 
absorption methods. Na+ and u+ binding constants to RBC membranes will be obtained by 
James-Noggle plots from the observed 23Na T1 and 
7Li T 1 values. 
31P NMR will be applied 
to measure phospholipid composition and intracellular Mgz+ concentrations. The correlations 
of RBC Na+-u+ exchange activity with Na+ and Lt binding to RBC membranes and their 
phospholipid compositions, as well as with total phospholipid concentrations, and intracellular 
free Mg2+ concentrations in RBCs from essential hypertensive patients and normotensive 
individuals will be determined from Spearman correlation matrices. 
m. t .Materials 
Ill.IA. Re412ents 
CHAPTER III 
EXPERIMENTAL APPROACH 
Choline chloride, glucose, sucrose, magnesium chloride (MgClJ hexahydrate, lithium 
chloride (LiCl), sodium chloride (NaCl), dimethyl sulfoxide (DMSO), methanol (anhydrous) 
(MeOH), chloroform (CHC13), deuterated chloroform (CDC13), potassium chloride (KCl), 
deuterium oxide (99.8% 0 20), sodium hydroxide, triethylenetetraamine hexacetic acid 
(H61THA), and dysprosium chloride (DyCl3) were supplied by Aldrich (Wisconsin). 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), [Ethylenedinitrilo ]tetraacetic acid 
(EDTA, 99%), butylated hydroxytoluene (BHT), tris(hydroxymehtyl)aminomethane (TRIS), 
2-[N-morpholino]ethanesulfonic acid (MES), 3-[N-morpholino]propanesulfonic acid (MOPS), 
albumin bovine serum (ABS), ouabain, phloretin, bumetanide, 4,4' -diisothiocyanatostilbene-
2,2'-disulfonic acid (DIDS), methazolamide, the detergent octyl-~D-gluco pyranoside, and the 
calcium ionophore A23187 were purchased from Sigma Chemical Company (St. Louis, MO). 
Methylphosphonic acid (MeP) was purchased from Alfa Products (Ward Hill, MA). 
Amiloride, 5-(N ,N-hexamethylene)-amiloride (HMA), 5-(N-ethyl-N-isopropyl)-amiloride 
(EIPA), and 5-(N-methyl-N-isobutyl)-amiloride (MIA) were supplied from Research 
Biochemicals International (Natick, MA). The protein assay dye reagent was obtained from 
Bio-Rad Chem. Co .. 
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ill.lB. Blood Samples 
Fresh packed red blood cells (RBCs) were supplied from a blood bank (Chicago Chapter 
of Life Source). Whole blood samples from three male and seven female essential 
hypertensive patients (not having hypothyroidism, diabetes mellitus, hyperlipidemia, obesity, 
pregnancy, or other condition which could affect blood pressure) and from three male and 
seven female normal individuals were obtained through the Hypertension and Renal Section 
of the Loyola University Medical Center. Normal individuals were matched with the patients 
according to gender, race and age. Because RBC Na+ -Li+ exchange activity is elevated in 
white, but not in black, hypertensive patients (Canessa et al., 1991; Canessa et al., 1993), 
all subjects used in this study were Caucasians. The protocols for the experiments were 
approved by the Institutional Review Board Committee. The selection of essential 
hypertensive patients used in this study was based on medical history. Some of the patients 
were receiving antihypertensive medication (verapramil, triamterene, atenolol, enalapril, 
clonidine, and/or hydrochlorothiazide) at the time of blood drawing. All normotensive 
individuals had a diastolic blood pressure s 80 mmHg at the time of blood drawing. All 
patients and normotensive individuals used in this study had no dietary restriction and ate salt 
freely; they were instructed to fast for a minimum of 12 hr prior to blood drawing. 
Triglyceride and cholesterol concentrations were measured for all samples by the clinical 
laboratory of the Loyola University Medical Center. 
m.2.Sample Preparation 
ill.2A. Preparation of Li"+ -loaded RBCs 
Washed RBCs were added to a lithium loading solution (150 mM LiCl, 10 mM glucose, 
and 10 mM HEPES, pH 7.4) at 10% hematocrit and incubated at 37°C for 3 hours. After 
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incubation, extracellular Li+ was removed from the Li+ -loaded RBCs by washing four times 
with CWS (Canessa et al., I 980a). 
Ill.28. Preparation of H+ - and u+ -IQaded Resealed RBC Ghosts 
RBCs were washed three times using CWS. Ice-cold packed RBCs were added to ice-
cold hemolyzing medium (5 mM TRIS-MES, pH 6.0, 4 mM MgCl2, 21 mM LiCI, 70 ± 10 
mOsM) at 10% hematocrit. After mixing for 10 minutes at 0°C-2°C, the isotonicity was 
restored to 300 ± 10 mOsm by adding choline chloride. Subsequent to stirring for an 
additional 10 minutes at 0°C, the suspensions were incubated for 1 hour at 37°C to reseal 
the ghosts. The pH was adjusted to 6.0 during the incubation. After incubation, the ghosts 
were washed twice with CWS (pH 6.0) at 2 °C (Bodemann and Passow, 1972; Duhm et al., 
1976). 
1Il.2C. Preparation of Unsealed RBC Membranes 
Unsealed RBC membranes were prepared by lysing the washed packed RBCs with 5 mM 
HEPES buffer, pH 8.0 (5H8). The membranes were washed three more times with 5H8 and 
centrifuged at 51948 g at 4°C until the membranes were pale white (Steck and Kant, 1974). 
Ill.2D. Preparation of Shift Reagents 
For the preparation of 5 mL of 0.125 M Na3DyTIHA, 0.2356 g DyC13 and 0.3090 g 
H6ITHA were added to 3 mL water and titrated with 30 µ.L aliquots of 2.5 M NaOH until 
all of the salts were dissolved while stirring. The pH was maintained lower than 8.0 during 
the titration. Then the solution was transferred to a 5 mL volumetric flask and made up to 
5 mL. Tetramethylammonium hydroxide was used instead of NaOH in case sodium had to 
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be excluded from the experiments (Pike et al., 1983). 
1Il.2E. Preparation of Mg2+ -Saturated RBCs 
Washed packed RBCs were added to a Mg2+ -loading solution (112.5 mM choline, 75 
mM sucrose, 10 mM glucose, 20 mM MgC12, 4 mg/L A23187, and 10 mM HEPES, pH 7.4) 
at 15% hematocrit, and were incubated at 37 °C for 45 minutes. After incubation, Mg2+ -
loaded RBCs were packed by centrifugation at 3928 g and washed four times using CWS at 
4 °C (Bock et al., 1985; Flatman, 1988). 
Ill.2F. Preparation of Mil+ -Depleted RBCs 
Washed packed RBCs were added to a Mg2+-depleting solution (112.5 mM choline, 75 
mM sucrose, 10 mM glucose, 20 mM EDTA, 4 mg/L A23187, and 10 mM HEPES, pH 
7.4) at 15% hematocrit, and were incubated at 37 °C for 45 minutes. After incubation, 
Mg2+ -loaded RBCs were packed by centrifugation at 3928 g and washed four times using 
CWS at 4 °C (Flatman, 1988). 
ID.2G. Extraction of Phospholipids 
The phospholipids in the RBC membrane were extracted as follows: 17 mL methanol was 
added to 1 mL membrane and mixed for 10 minutes. Then 33 mL chloroform was added, 
and the sample was mixed for an additional 15 minutes. All extracting solvents contained 50 
mg/L of butylated hydroxytoluene (BHT) as an antioxidant. The resulting extract was filtered 
through a sintered glass funnel, and was washed with 50 mL of a chloroform, methanol 
mixture in the ratio of 2: 1. The filtrate was washed with 0.2 times its total volume with 
0.74% KCl to remove all non-lipid impurities. The bottom chloroform layer was collected 
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and dried in a rotary evaporator at 30°C. 
m.3.Instrumentation 
IIl.JA. Nuclear Mrumetic Resonance Spectrometer 
23Na, 7Li, and 31P measurements were obtained at 79.4, 116.5, and 121.4 MHz, 
respectively, on a Varian VXR-300 NMR spectrometer. The instrument was equipped with 
10 mm multinuclear probes and a variable temperature unit. All NMR experiments were run 
under identical gain settings. 
7Li NMR spectra for Lt efflux across resealed RBC ghosts were obtained using a flip 
angle of 60° (18 µs), an acquisition time of 0.981 s, a 30 s delay, a spectral width of 4500.5 
Hz, and 29 transients, with 10 Hz spinning and at 37 °C. 
31P NMR spectra for measuring the chemical shift difference between the aP and the 
/3P resonances of ATP to determine intracellular free Mgz+ concentrations were obtained 
using a flip angle of 60° (7 µs), an acquisition time of 1.37 s, a 0 s delay, a spectral width 
of 10000.0 Hz, and 1500 transients, without spinning and at 37 °C. 
31P NMR spectra for analyzing phospholipid compositions in the extracts of RBC 
membranes were obtained using a flip angle of 60° (7 µs), an acquisition time of 1.37 s, a 
4 s delay, a spectral width of 1051.3 Hz, and 15000 transients, with 16 Hz spinning and at 
37 °C. 
23Na and 7Li spin-lattice relaxation time {T1) measurements were conducted by the 
inversion recovery method (180°--r-90°) with 16 Hz spinning and at 37 °C. The delay time 
was at least five times the value of T 1• 
ID.JB. Atomic Absorption Spectrophotometer 
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Li+ and Na+ absorption were measured at 670.8 and 589.0 nm, respectively, on a Perkin 
Elmer 5000 spectrophotometer equipped with a flame source and a graphite furnace. The slit 
width was set at 1.4 high for both Li+ and Na+. The fuel and oxidant were acetylene and 
compressed air. The flow rate for fuel and oxidant were 45 and 50, respectively. 
1Il.3C. UV/Vis Spectrophotometer 
The protein and hemoglobin concentrations were measured at 595 nm and 415 nm, 
respectively on an IBM UV/Vis 9420 or on a JASCO MODEL V-500 UV/VIS 
spectrophotometer. 
ill.3D. (:entrifuee 
A Savant refrigerated centrifuge, model HSC 1000, was used for separating and washing 
RBCs. Resealed RBC ghosts and unsealed RBC membranes were prepared by using a 
Beckman J2-21 refrigerated centrifuge equipped with fixed angle rotors, JA-10 and JA-20. 
III.3E. Osmometer 
The osmolarity of the suspension medium was checked with a Wescor Vapor Pressure 
Osmometer (Wescor Inc., Logan, UT). 
III.3F. Hemofuee 
Hematocrits were measured by an IEC model MB IMl 16 hemofuge. 
IIl.4.Data Analysis 
ill.4A. Determination of Kinetic Parameters of RB(: Na+ ·Li+ Countertransport 
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The Li+ loaded RBCs were suspended at 10% hematocrit in six media containing 150, 
100, 70, 40, 20 and 0 mM NaCl that were made isotonic with choline chloride and also 
contained 10 mM glucose, 0.1 mM ouabain, and 10 mM HEPES, pH 7.4. Aliquots were 
taken every 20 minutes from each of the Li-loaded RBC suspensions and centrifuged at 10519 
g for 1.5 minutes at 4 °C. The supernatants were collected and analyzed by AA. The kinetic 
parameters of Na+ -Li+ exchange V,14, v_ .. and K,,. were obtained from the following equations 
(Canessa et al., 1980a; Rutherford et al., 1990): 
(12) 
(13) 
(14) 
111.48. Determination of Li+ Effiux Rates Across H+ - and Li+ - loaded Resealed 
RBC Ghosts bv 7Li NMR 
Li+-loaded resealed BRC ghosts were added to a NaCl medium containing 120 mM 
NaCl, 10 mM glucose, 0.1 mM ouabain, 5 mM N~DyTTHA, 10 mM TRIS-MES for pH 
6.0, or 10 mM TRIS-MOPS for 8.0, with or without 0.1 mM phloretin or 0.1 mM HMA at 
20% hematocrit. 7Li NMR measurements were taken every 15 minutes. Extracellular Li+ 
concentrations were calculated by the following equation: 
(15) 
where Aout was the peak area under the extracellular Li+ NMR resonance, [Li+], and A. were 
the known concentration and peak area of a standard u+ solution which was measured 
separately, and Ht was the hematocrit. Li+ efflux rates were obtained by the equation shown 
below: 
Rate = Slopex(l-Ht)/Ht (16) 
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IIl.4C. Determination of Na• Bindine Constants to RBC Membranes from 'Li T, 
Measurements 
The observed 23Na or 7Li NMR relaxation values measured in RBC membrane 
suspensions represent the weighted average of free and bound Na• or Li• ions; these values 
are thus sensitive to ion binding to the RBC membrane and total intracellular ion 
concentrations. Free and bound Na+ and u· are undergoing exchange which is represented 
by a time-averaged expression: 
(17) 
James and Noggle introduced graphical methods to calculate metal ion binding constants 
(James and Noggle, 1969) which express the interactions between metal ions and cell 
membranes and assume one to one stoichiometry for binding at a microscopic level when [BJ 
~ [M•J: 
(_6R)"I = (R.-Rr....J·I 
=Kb"1{[BJ(R1>ounci-Rr....Jr' + [M+]{[BJ~-Rr....J}" 1 (18) 
where R1, R1r-· and R,bound were the observed, free, and bound relaxation rates of M+ ions 
in RBC membrane suspension, Xr- and~ were the mole fractions of free and bound M+, 
[M+J and [BJ were the total concentration of M+ and membrane binding sites, respectively. 
A series of 7Li T 1 values were measured for unsealed RBC membranes with varying 
concentrations of Na+ titrated with u• at increasing concentrations. Apparent u+ binding 
constants Ku"PP to unsealed RBC membranes were obtained from James-Noggle plots (James 
and Noggle, 1969). 
Because Na ... and u· competitively bind to RBC membranes, the u• binding constant 
Ku and the actual Na• binding constant KN•<•l were determined by the following equation: 
(19) 
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The observed Na+ binding constants to the same membrane preparations were calculated 
from the observed 23Na T 1 values for the membrane suspensions titrated with Na+ at 
increasing concentrations by James-Noggle plots (James and Noggle, 1969). 
The ratio of the actual Na+ binding constant to the observed Na+ binding constant was 
calculated by equation (20): 
r = KN•(•) I Kr.o(o) (20) 
Ill.40. Determination of Inhibitor Bindine Constants to RBC Membranes in the 
Presence of Na• and u• 
The inhibitory activity of the inhibitors, such as amiloride, HMA, and phloretin, for 
Na+ or u• binding to RBC membranes can be addressed by measuring inhibitor binding 
constants to RBC membranes in suspensions in the presence of Na+ or u+. As a competitive 
inhibitor (Potts, 1994), the kinetic behavior of amiloride can be expressed by the equation 
(21): 
(21) 
where KM"PP was the apparent binding constant of the metal ion M ... , KM was the metal ion 
binding constant, [I] was the inhibitor concentration, and K1 was the inhibitor binding 
constant. The apparent Na+ or u+ binding constants to unsealed RBC membranes were 
calculated from James-Noggle plots (James and Noggle, 1969) from the 23Na or 7Li T1 values 
observed in RBC membrane suspension in the presence of varying concentrations of amiloride 
titrated with Na+ or Li+ at increasing concentrations. 
Because Li+ is 100% visible by 7Li NMR, the apparent Li+ binding constants were 
directly used in equation (21) to generate the inhibitor binding constants. Because Na+ is not 
100% visible by 23Na NMR, the apparent binding constants were corrected by multiplying the 
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corresponding correction factor from the curve in Figure 8. Then the corrected Na+ binding 
constants were used to generate inhibitor binding constants to the RBC membranes in the 
presence of Na+ using equation 21. 
III.4E. Determination of Intracellular Free Mi+ Concentration from 31P NMR 
C:hemical Shifts 
Fresh blood was washed three times with CWS. 31P NMR measurements were taken 
for washed and packed RBCs. The chemical shift difference between the aP and the /3P 
resonances was used to determine the portion of total intracellular ATP that exists as the 
Mg2+ complex; the free Mg2+ concentration, which is related to the apparent dissociation 
constant of MgATP, can be obtained by the following equation (Gupta and Gupta, 1987): 
</> = (ATP)/(ATP)t = (oafJoeu - oatgA~/(oatrP - OafJMsA~ (22) 
[Mg2+), = K0MIA,,(1 -</>)/</>] (23) 
where KoMgATP was the apparent dissociation constant of MgATP, oa{Joell was the chemical shift 
difference between the aP and {3P resonances of intracellular ATP. oa/TP and oafJMgATP were 
the values of this difference for magnesium-depleted and magnesium-saturated RBCs, 
respectively, measured by 31P NMR. [ATP]l was the total ATP concentration in the cell, and 
[ATP], was the sum of the concentrations of all ATP species not chelated to magnesium. 
K 0 MgATP is temperature dependent. At 37 °C, the value of K 0 MgATP was determined to be 38 
± 4 µM, but at 25 °C, it was found to be 45 ± 8 µM (Gupta and Gupta, 1987; Resnick et 
al., 1984). 
III.4F, Ouantitation of Phospholipid Compositions and Total Phospholipid in Human 
RBC Membranes by 31P NMR 
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The purified phospholipids were suspended in 3 mL of the solvent mixture solution 
(CDC13 : MeOH : 0.2 M EDTA = 125 : 8 : 3). The sample was placed in a 10 mm NMR 
tube and was measured using 31 P NMR. The areas of each peak of the phospholipid extracts 
were integrated using the integration software of the NMR spectrometer, and the percentage 
of each phospholipid composition was calculated (Edzes et al., 1992). A known amount of 
pure PC was added to the same extract and was measured again using 31P NMR. The 
increased peak area corresponding to the added pure PC was used to calculate the total 
phospholipid by the following equation: 
TP ={(Ape/ Aj x (WPC/ Vj x V} I {Vm X [Pro] x PC%} (24) 
where TP was the total phospholipid, W PC was the known amount of the added PC, Ape and 
V were the area of PC from the 31 P NMR spectrum and the total volume of the solvents used 
to dissolve the phospholipid extract, respectively, A. and V, were the increased area of PC 
from the measured 31P NMR spectrum and the volume of the phospholipid sample when the 
known amount of PC was added, respectively, Vm was the volume of membrane used, [Pro) 
was the protein concentration of the membrane, and PC% was the percentage of PC in the 
total phospholipid extract. 
III.4G. Protein Concentration Determination 
The membrane protein concentration was measured by the "Bradford Assay" method 
(Bollag and Edelstein, 1991) with the detergent hexyl-,8-D-glucopyranoside or octyl-,8-D-
glucopyranoside (Fanger, 1987) at 595 nm by UV/Vis. 5 µL membranes was added to 45 
µL of 5 IIll\1 HEPES solution, pH 8.0, with 10 µL 50% detergent, and incubated 5 minutes 
at room temperature. Then 2.5 mL of dye reagent, which was purchased from Bio-Rad 
Chem. Co., was diluted with 4 fold deionized water was added to the membrane suspension. 
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The dye reagent was filtered through a Whatman No. 1 paper before it was added to the 
membrane suspension. 
III.4H. Statistical Analysis 
Each essential hypertensive patient was matched to a normotensive individual according 
to age, race and gender. The statistical significance of the differences between hypertensive 
patients and normal individuals for the kinetic parameters of RBC Na+ -Li+ exchange, Na+ 
and Li+ binding constants, phospholipid compositions and total phospholipid concentrations 
of RBC membranes, and intracellular free Mg2+ in intact RBCs were analyzed by one-way 
analysis of variance (ANOVA) with Tukey's conservative correction. p s 0.05 was 
considered significantly different. Correlation coefficients among these parameters were 
obtained by using Spearman correlation; correlation coefficients ;;::::; 0.40 were considered 
significant (p S 0.05). 
CHAPTER IV 
RESULTS 
IV.1.Na•-Li+ Exchange Activity in Intact Human RBCs with and without Inhibitors 
The Na+ -Li+ countertransport rates and the Na+ dissociation constants to intact RBCs 
in the presence and absence of inhibitors measured by AA spectroscopy along with the 
statistical analysis are shown in Tables 1 and 2. Amiloride had a significant effect on V max 
(0.23 ± 0.01 vs. 0.34 ± 0.05 mmol Li+ /L cells · h, p = 0.04, n = 3), but had no 
significant effects on V,l/J and K,,,. HMA had significant effects on v _ ... and K,,, (V _ ... and K,,, 
were 0.20 ± 0.03 mmol Li+/L cell· hand 48 ± 17 mM with HMA vs. 0.34 ± 0.05 mmol 
Li+/L cell · h, and 117 ± 13 mM w/o inhibitors, p ~ 0.03, n = 3), but had no significant 
effects on V,llJ· Phloretin had significant effects on V,l/J, V ,,,...., and K,,, (V.llJ, v _ ... , and K,,, were 
0.079 ± 0.014, 0.10 ± 0.01 mmol Li+ /L cell · hand 45 ± 13 mM with phloretin vs. 0.19 
± 0.04, 0.34 ± 0.05 mmol Li+/L cell · h, and 117 ± 13 mM without inhibitors, p ~ 0.03, 
n = 3). From Tables 1 and 2 we can see that HMA, an amiloride analogue, is more 
effective than amiloride. HMA, which is a Na+ -H+ exchange inhibitor, and phloretin, which 
is a Na+ -Li+ exchange inhibitor both inhibited the Na ... -Li+ exchange activity in intact RBCs. 
IV .2. Li+ Emux Across H+ - and u• -Loaded Resealed RBC Ghosts 
The pH value inside the ghosts was 6.0. When H+- and Li+-loaded resealed RBC 
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Table I. Na+ -Li+ Countertransport Rates (mmol Lr /L RBCs · h), and Na+ Dissociation Constants (mM) in the Presence and 
Absence of Inhibitors. 
w/o Inhibitor w/0.1 mM Amiloride w/0.1 mM HMA w/0.1 mM Phloretin 
2 3 2 3 2 3 2 3 
v.IJJ 0.23 0.16 0.19 0.16 0.18 0.20 0.23 0.11 0.22 0.099 0.073 0.065 
vm .. 0.41 0.29 0.32 0.25 0.22 0.23 0.20 0.17 0.24 0.11 0.10 0.089 
115 134 103 113 39.2 54.6 48.9 67.1 26.7 26.5 55.7 52.9 
0.99 0.99 0.97 0.97 0.99 0.97 0.97 0.99 0.96 0.99 0.99 0.99 
Table 2. Student's t-test p Values, and Average Values for Na+ -Li+ Countertransport Parameters for Intact RBCs in the Presence 
and Absence of Amiloride, HMA and Phloretin. 
w/o Inhibitor w/0.1 mM Amiloride w/0.1 mM HMA w/0.1 mM Phloretin 
(n = 3) (n = 3) • p (n = 3) • p (n = 3) • p 
v.IJJ 0.19±0.03 0.18±0.02 0.60 0.19±0.05 0.89 0.079±0.014 0.01 
vm .. 0.34±0.05 0.23±0.01 0.04 0.20±0.03 0.03 0.10±0.01 0.03 
117±13 69±32 0.12 48±17 0.01 45±13 0.01 
*p ~ 0.05 is considered significantly different. 
Vl 
0 
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ghosts were suspended in NaCl medium at pH 8.0, there was a pH gradient. Both u+ and 
H+ from inside the ghosts exchanged with Na+ from the outside medium. Both Na+ -Li+ and 
Na+- H+ exchange occurred simultaneously. As shown in Figure 7, u· came out more 
slowly when Na• -H+ exchange also occurred at the same time, with or without inhibitors. 
Both HMA and phloretin decreased Li+ efflux. The Li+ efflux rates were calculated and are 
shown in Table 3. Li+ efflux rates across resealed H+ - and u• -loaded RBC ghosts were 
significantly lower in the presence of a pH gradient than in its absence (0.48 ± 0.09 vs. 0.81 
± 0.09 without inhibitors; 0.28 ± 0.05 vs. 0.49 ± 0.08 with 0.1 mM HMA; 0.25 ± 0.04 
vs. 0.41 ± 0.06 mmol Li+/L cell·h with phloretin) presumably due to the competition 
between u· and H• for transport by the same transport protein. HMA significantly 
decreased u• efflux rates (0.49 ± 0.08 vs. 0.81 ± 0.09 in the absence of a pH gradient; 
0.28 ± 0.05 vs. 0.48 ± 0.09 mmol u·1L cell·h in presence of a pH gradient). Phloretin 
also significantly decreased Li+ efflux rates (0.41 ± 0.06 vs. 0.81 ± 0.09 in the absence of 
a pH gradient; 0.25 ± 0.04 vs. 0.41 ± 0.06 mmol Li+ /L ghosts·h in the presence of a pH 
gradient). 
IV.3.Na• Visibility in RBC Membranes and the Correction Curve 
IV.3A. Na+ Visibility in RBC Membranes 
23Na NMR visibility in RBC membrane suspension was measured by comparing the 
signal intensities of Na• in RBC membranes with those in water solutions at the same Na+ 
concentrations. Table 4 shows results from two trials for the Na• visibility and 23Na T 1 
values in RBC membranes by 23N a NMR without and with 150 mM LiCl. When there was 
no LiCl, sodium is not 100% visible. The lower the Na• concentration, the lower the 
visibility. 23Na T 1 values at lower Na• concentrations were lower than 
23Na free T 1 when 
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Figure 7. 7Li NMR Spectra of u· Efflux Across H•- and u•-loaded Resealed RBC Ghosts 
in NaCl Media. Acquisitions were accumulated every 15 min. The pH inside of the resealed 
ghosts was 6.0 for all of the cases. The pH outside of the resealed ghosts was 6.0 for the 
sets of spectra a, b, and c. The pH outside of the resealed ghosts was 8.0 for the sets of 
spectra d, e, and f. There was no inhibitor in NaCl media for the sets a and d. There was 
0.1 mM HMA in the NaCl media for the sets b and e. There was 0.1 mM phloretin in the 
NaCl media for the sets c and f. 
53 
• 1n • 1n . In 
a b c 
d e f 
• • . • • • • . • • - . i 
54 
Table 3. Li+ Efflux Rates (mmol Li+ /L Ghosts · h) Across H+ - and Li+ -loaded Resealed 
RBC Ghosts in NaCl Medium with and without Inhibitors. (n = 3) 
pH,_> w/o Inhibitor 
6 0.81 ± O.OCJ 
8 0.48 ± O.OCJ 
All pHcm> : 6. 
w/0.1 mM HMA 
0.49 ± 0.08 
0.28 ± 0.05 
w/0.1 mM Phloretin 
0.41 ± 0.06 
0.25 ± 0.04 
Table 4. 23Na Visibility in RBC Membrane Suspensions by NMR. 
4 
12 
20 
500 
Membranes/w/o LiCl• 
Visibility (%) T/ms 
52.8 ± 0.4 
78.6 ± 0.5 
95.2 ± 3.2 
91.6 ± 2.8 
39.9 + 3.0 
46.9 ± 2.0 
50.5 ± 0.6 
65.1 ± 0.4 
*Average of the values were obtained from two trials. 
Membranes/w/150 mM LiCI9 
Visibility (%) T/ms 
100.2 ± 3.0 61.4 ± 1.0 
99.8 ± 5.0 62.5 ± 2.0 
96.0 ± 5.6 63.8 ± 2.0 
92.4 ± 2.1 65.3 ± 0.2 
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there was no LiCl present. After 150 mM LiCl was added to the same membrane suspension 
at the same Na+ concentrations, 23Na T, values were close to 23 Na free T,, and Na+ was fully 
visible at any Na+ concentrations thereafter. 
IV .38. Actual Na+ Bindinf: Constants to RBC Membranes 
The sodium-23 nucleus is not 100% visible by 23Na NMR. The obseived 23Na T, values 
are not the actual T 1 values. Therefore the Na+ binding constants calculated by James-Noggle 
plots from the obseived T, values are not the actual Na+ binding constants. The actual Na+ 
binding constants were obtained by measurements of 7Li T 1 values in RBC membrane 
suspensions in the presence of varying concentrations of Na+ at increasing concentrations of 
Li+. Tables 5 through 9 show 7Li T, measurements for RBC membranes in the presence of 
varying concentrations of NaCl. The obseived Na+ binding constants were obtained from the 
obseived 23Na T, values. At a given Na+ concentration, when the Li+ concentrations 
increased, 7Li T1 values also increased. When Na+ concentrations were elevated, 7Li T, 
values increased for the same Li+ concentrations, and apparent Li+ binding constants 
decreased. 
IV.3C. Ratio of the Actual Na+ Bindin1: Constants to the Observed Na+ Bindinf: 
Constants to RBC Membranes and the Correction Curve 
Both the obseived and the actual Na+ binding constants differed from batch to batch of 
human blood obtained from the Life Source. The obseived and the actual Na+ binding 
constants show, however, the same trends. The blood that gave higher observed Na+ binding 
constants also gave higher actual Na+ binding constants. The ratios of the actual Na+ binding 
constant to the observed Na+ binding constant are listed in Table 10. All of the ratios are 
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Table 5. 7Li T1 Measurements (s) for RBC Membranes in the Presence of Varying 
Concentrations of NaCl. (Trial 1) 
2 
4 
6 
8 
10 
12 
500 
0 
5.0±0.7 
5.9±0.9 
6.4±0.2 
7.5±0.3 
9.1±0.8 
9.2±0.5 
19.5±0.8 
174 
0.98 
2 
5.9±0.7 
8.1±0.6 
8.1±0.3 
8.2±0.2 
9.2±0.2 
10.0±0.4 
23.0±2.4 
158 
0.88 
~U) = 283 M'1 KN•(•)= 618 M'1 
KNa(o; = 254 M'1 
5.7±0.5 
8.0±0.6 
9.2±0.4 
8.8±0.2 
9.2±0.2 
9.5±0.2 
22.9±3.2 
107 
0.88 
r2 = 0.94 
6 
8.4±0.6 
9.0±0.3 
9.0±0.3 
10.9±1.0 
10.1±0.2 
10.5±0.2 
22.2± 1.8 
54 
0.98 
10 
9.2±0.6 
9.6±0.6 
10.1±0.3 
10.3±0.3 
10.6±0.3 
12.3±0.6 
21.5±1.9 
39 
0.98 
*KN•<o> was obtained by 23Na T1 measurements for the same membrane preparation. 
Protein concentration was 6.11 ± 1. 70 mg/mL. 
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Table 6. 7Li T1 Measurements (s) for RBC Membranes in the Presence of Varying 
Concentrations of NaCl. (Trial 2) 
2 
4 
6 
8 
10 
12 
500 
0 
5.1±0.3 
5.6±0.2 
5.7±0.3 
7.0±0.6 
7.7±0.4 
7.6±0.2 
17.3±0.3 
171 
0.90 
2 
6.2±0.4 
6.5±0.2 
6.7±0.4 
7.0±0.2 
8.8±0.7 
8.8±0.6 
18.3±0.8 
122 
0.82 
~ = 175 M"1 KNa(a) = 182 M"1 
KNa(o; = 153 M"1 
[Na.]/mM 
4 
6.5±0.7 
6.0±0.2 
7.2±0.3 
8.3±0.4 
8.8±0.2 
9.0±0.3 
17.7±0.7 
109 
0.94 
6 
6.6±0.4 
8.1±0.5 
8.9±0.8 
8.6±0.3 
9.6±0.7 
10.3±0.7 
21.1 ±2.4 
85 
0.74 
r2 = 0.99 
10 
7.5±0.5 
7.8±0.2 
8.5±0.2 
8.6±0.2 
9.4±0.5 
11.3±1.2 
20.9±2.0 
64 
0.96 
*KN•<o> was obtained from 23Na T1 measurements for the same membrane preparation. 
Protein concentration was 6.11 ± 1. 70 mg/mL. 
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Table 7. 7Li T1 Measurements (s) for RBC Membranes in the Presence of Varying 
Concentrations of NaCl. (Trial 3) 
2 
4 
6 
8 
10 
12 
500 
0 
6.3±0.5 
6.8±0.2 
6.9±0.2 
8.3±0.8 
8.9±0.5 
8.5±0.5 
18.8± 1.8 
161 
0.96 
2 
6.4±0.4 
7.0±0.2 
7.6±0.6 
7.7±0.2 
8.2±0.5 
8.5±0.2 
18.0±0.6 
119 
0.91 
~U) = 174 M 1 KN•(•)= 234 M 1 
KNa(o; = 181 M"' 
6.9±0.5 
6.6±0.2 
7.3±0.1 
8.3±0.3 
8.5±0.1 
9.2±0.6 
17.8±0.8 
101 
0.98 
r2 = 0.94 
6 
7.8±0.6 
8.8±0.3 
8.7±0.3 
9.4+0.4 
9.5±0.6 
9.3±0.3 
18.1±1.1 
68 
0.91 
10 
7.6±0.1 
9.0±0.7 
9.7±0.6 
8.8±0.3 
9.8±0.3 
9.8±0.4 
17.3±0.4 
84 
0.79 
*KN•<o> was obtained from 23Na T1 measurements for the same membrane preparation. 
Protein concentration was 6.11 ± 1. 70 mg/mL. 
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Table 8. 7Li T1 Measurements (s) for RBC Membranes in the Presence of Varying 
Concentrations of NaCl. (Trial 4) 
2 
4 
6 
8 
10 
12 
500 
0 
3.2±0.2 
4.3±0.2 
4.7±0.2 
5.2±0.2 
6.2±0.4 
6.4±0.3 
16.2±0.4 
222 
0.98 
2 
4.0±0.2 
4.9±0.2 
5.4±0.1 
6.3±0.4 
6.7±0.4 
6.7±0.1 
17.2±0.9 
150 
0.95 
~) = 208 M"1 KNa(a) = 185 M"' 
KNa(o; = 153 M"' 
[Na+]/mM 
4 
4.1±0.1 
4.8±0.1 
5.9±0.3 
6.5±0.4 
6.9±0.2 
7.4±0.5 
16.5±0.4 
193 
0.99 
r2 = 0.99 
6 
5.4±0.4 
6.4±0.5 
6.6±0.3 
6.9±0.2 
7.4±0.2 
8.0±0.2 
17.8± 1.1 
94 
0.97 
10 
6.0±0.3 
7.2±0.3 
8.0±0.4 
7.9±0.3 
8.9±0.7 
8.4±0.4 
16.7±0.6 
75 
0.81 
*KN•<o> was obtained from 23Na T, measurements for the same membrane preparation. 
Protein concentration was 6.11 ± 1. 70 mg/mL. 
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Table 9. 7Li T1 Measurements (s) for RBC Membranes in the Presence of Varying 
Concentrations of NaCl. (Trial 5) 
2 
4 
6 
8 
10 
12 
500 
0 
5.6±0.6 
6.5±0.2 
7.3±0.2 
7.7±0.3 
8.4±0.3 
8.9±0.l 
20.0±0.7 
191 
0.95 
2 
5.7±0.8 
6.9±0.4 
7.0±0.1 
8.5±0.3 
9.2±0.1 
10.8±0.3 
20.4±0.8 
162 
0.99 
~) = 272 M"1 KN•(•) = 372 M'' 
KNa(o)• = 215 M'1 
[Na+]/mM 
4 
7.6±0.5 
7.0±0.3 
7.9±0.2 
9.2±0.3 
10.8±0.4 
10.5±0.2 
20.8±0.6 
129 
0.88 
r2 = 0.94 
6 
8.4±1.5 
7.7±0.7 
8.2±0.3 
9.8±0.5 
10.6±0.6 
10.9±0.4 
22.0±1.8 
99 
0.83 
10 
10.9±1.0 
10.0±0.6 
10.8±0.3 
11.6±0.3 
11.5±0.1 
11.7±0.1 
20.6±0.9 
52 
0.81 
*KN•<o> was obtained from 23Na T, measurements for the same membrane preparation. 
Protein concentration was 6.11 ± 1. 70 mg/mL. 
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Table 10. Ratio of Actual Na+ Binding Constants to Observed Na+ Binding Constants to RBC 
Membranes. 
KNa(a/M1 
KNa(o/Ml 
1 
618 
254 
2.43 
2 
182 
151 
1.20 
3 
234 
181 
1.29 
4 
185 
153 
1.21 
5 
372 
215 
1.73 
63 
higher than 1. 00. From Table 10 we generated the correction curve shown in Figure 8. 
At lower binding constants, the correction factors were close to l.00, and the actual Na+ 
binding constants were very close to the observed Na+ binding constants. 
IV.4.lnhibitory Activities or Amiloride and Its Analogues on Na+ and u• Interactions 
with RBC Membranes 
IV.4A. Inhibitory Effects or Amiloride and Its Analogues on 13Na and 7Li 
Relaxation Times 
The inhibitory effects of amiloride and its analogues, EIPA, HMA and MIA on both 
23Na and 7Li spin lattice relaxation times were tested by measuring 23Na and 7Li T1 with 
increasing concentrations of these inhibitors. As shown in Tables 11 and 12, and Figure 9, 
at the same Na+ and Li+ concentration 23Na and 7Li T1 values increased as the concentration 
of all these inhibitors increased. All of these inhibitors bound to the protein in the RBC 
membranes, which also contain the Na+ and Li+ binding sites, and resulted in more free Na+ 
and Li+. HMA had the highest inhibitory effects though the effects of all of these inhibitors 
were of the same order of magnitude. 
IV.48. Amiloride Inhibitory Activities on Na+ and Li+ Bindin& to RBC Membranes 
Tables 13 through 20 show 23Na and 7Li T1 measurements for RBC membrane 
suspensions with increasing concentrations of Na+ or Li+ in the presence of varying 
concentrations of amiloride (0, 0.5, 1.0, 1.5, 2.0, 2.5 mM) at pH 7.0 and 8.0. One of the 
two trials of both 23Na and 7Li T1 measurements at pH 8.0 is ploted in Figure 10. At the 
same amiloride concentrations, 23Na or 7Li T1 values increased as Na+ or u+ concentrations 
increased. At the same Na+ or u+ concentrations, as amiloride concentration elevated, both 
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Figure 8. Correction Factor for Na+ Binding Constants to RBC Membranes. pH value was 
7.6 ± 0.2. Protein concentration of the membrane samples was 6.11 ± 1.70 mg/mL. 
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Table 11. 23Na T1 Measurements (ms) for Membrane Samples in the Presence of Amiloride, EIPA, HMA, and MIA at pH 8.0. 
Inhibitors 
Amiloride 
EIPA 
HMA 
MIA 
0 
42.8± 1.0 
44.3±3.0 
45.9±2.0 
44.2±1.0 
1.0 
44.7±0.9 
45.7±0.9 
50.6±2.0 
45.2± 1.0 
2.0 
48.2± 1.0 
48.3±2.0 
49.3± 1.0 
49.5±3.0 
Concentration/mM 
3.0 
50.3±2.0 
49.2±2.0 
51.5±2.0 
47.9±2.0 
4.0 
55.0±1.0 
52.3±2.0 
53.9±2.0 
53.4±2.0 
5.0 
55.1±3.0 
53.1 ±2.0 
55.3±2.0 
52.6±2.0 
6.0 
56.1 ±1.0 
56.1 ±2.0 
57.6±2.0 
52.5±2.0 
The Na+ and protein concentrations in all membrane samples were 4 mM and 5.83 ± 0.02 mg/mL, respectively. 
Table 12. 7Li T1 Measurements (s) for Membrane Samples in the Presence of Amiloride, EIPA, HMA, and MIA at pH 8.0. 
Inhibitors 
Amiloride 
EIPA 
HMA 
MIA 
0 
7.5±0.2 
7.1 ±0.3 
7.9±0.1 
7.7±0.1 
1.0 
8.2±0.1 
9.5±0.2 
10.4±0.3 
9.9±0.3 
2.0 
9.4±0.2 
11.5±0.3 
11.6±0.2 
11.9±0.2 
Concentration/mM 
3.0 
10.2±0.1 
11.9±0.2 
13.5±0.3 
12.3±0.4 
4.0 
10.9±0.1 
12.7±0.2 
16.7± 1.0 
14.2±0.2 
5.0 
11.9±0.4 
14.4±0. l 
17.3±0.3 
15.9±0.4 
6.0 
12.7±0.3 
15.9±0.9 
17.2±0.6 
15.7±0.8 
The Lt and protein concentrations in all membrane samples were 4 mM and 5.01 ± 0.02 mg/mL, respectively. 
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Figure 9. 23Na (panel A) and 7Li (panel B) T1 Relaxation Times with Amiloride (squares), 
EIPA (triangles), HMA (diamonds), and MIA (dots). Na+ and Li+ concentrations were 4 
mM. Protein concentration in the membrane suspensions was 5.83 ± 0.02 mg/mL. pH was 
8.0. 
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Table 13. 23Na T1 Measurements (ms) for RBC Membranes in the Presence of Varying Concentrations of Amiloride at pH 7.0. 
(Trial 1) 
[Na+]/mM 
2 
4 
6 
8 
10 
12 
K "PP/M'' N1(1) 
0 
33.8±0.6 
39.0±0.6 
43.3±0.7 
46.0±1.0 
46.1±1.0 
49.1±0.8 
338 
0.97 
0.5 
35.6±5.0 
40.0±4.0 
45.0±4.0 
45.0±2.0 
46.6±1.0 
47.8±0.7 
206 
0.93 
[Amiloride]/mM 
1.0 1.5 
40.6±2.0 41.3±8.0 
42.9± 1.0 44.1±5.0 
47.9±2.0 46.0±2.0 
47.3± 1.0 47.8±0.6 
49.7± 1.0 49.7±0.3 
51.7±1.0 51.4±1.0 
234 207 
0.94 0.99 
Kb(Na) = 284 M'' KAmi(Na) = 1068 M'1 r2 = 0.87 
Protein concentration was 7.03 ± 1.44 mg/mL. 
2.0 2.5 
47.1 ±7.0 46.6±7.0 
50.2±2.0 47.4±4.0 
51.9±2.0 48.3±3.0 
55.4±2.0 49.9±2.0 
53.9±1.0 52.3±2.0 
54.8±0.8 51.6±1.0 
152 107 
0.98 0.89 
Table 14. 23Na T1 Measurements (ms) for RBC Membranes in the Presence of Varying Concentrations of Amiloride at pH 7.0. 
(Trial 2) 
2 
4 
6 
8 
10 
12 
K 'PP/M-1 Na(a) 
0 
40.1±1.0 
45.7±2.0 
47.2±0.8 
48.2±0.5 
49.6±0.7 
54.2± 1.0 
352 
0.87 
0.5 
45.9±3.0 
45.4±1.0 
49.0±0.9 
50.8±1.0 
58.2±0.7 
54.0±0.4 
220 
0.95 
[ Amiloride ]/mM 
1.0 1.5 
40.9±2.0 50.7±2.0 
47.4±1.0 50.4± 1.0 
51.0±0.6 52.3±0.8 
50.3±1.0 53.5±0.5 
52.5±0.9 53.7±0.8 
55.7±0.3 56.6±1.0 
272 143 
0.81 0.89 
~Na) = 240 M"1 KAmi(Na) = 973 M"1 r2 = 0.84 
Protein concentration was 7.03 ± 1.44 mg/mL. 
2.0 2.5 
47.4±2.0 51.1 ±0.6 
48.3±2.0 53.5±2.0 
55.3±0.9 52.8±0.9 
54.8±0.8 56.3±1.0 
58.0±0.8 56.1±0.5 
55.9± 1.0 59.3±0.6 
124 108 
0.88 0.82 
Table 15. 7Li T 1 Measurements (s) for RBC Membranes in the Presence of Varying Concentrations of Amiloride at pH '7.0. (fria\ 
1) 
[Amiloride]/mM 
[Li+]/mM 0 0.5 1.0 1.5 2.0 2.5 
2 7.2±0.7 9.3±0.4 9.2±0.8 8.8± 1.0 12.1 ±0.7 14.1±1.4 
4 8.8±0.2 8.6±0.2 12.4±0.7 10.5±0.4 11.8±.07 11.7±0.8 
6 9.9±0.3 10.9±0.4 10. l ±0.5 11.2±0.4 13. l ±0.7 11.8±0.6 
8 10.5±0.6 10.0±.02 12.3±0.8 12.7±0.3 12.5±0.3 12. l ±0.4 
10 10.4±0.2 11.7±0.6 11.1 ±0.4 12.2±0.2 12.5±0.3 13.0±0.6 
12 11.7±0.6 11.8±0.6 12.7±0.2 13.2±0.5 13.7±0.1 14.4±0.4 
150 97 84 80 50 83 
0.93 0.84 0.81 0.83 0.82 0.92 
Kb<LI> = 154 M-1 KAmi<LI> = 1004 M 1 r2 = 0.98 
Protein concentration was 7.03 ± 1.44 mg/mL. 
Table 16. 7Li T1 Measurements (s) for RBC Membranes in the Presence of Varying Concentrations of Amiloride at pH 7.0. (Trial 
2) 
[Amiloride]/mM 
[Li]/mM 0 0.5 1.0 1.5 2.0 2.5 
2 5.5±0. l 5.9±0.3 5.9±0.3 7.2±0.5 7.7±0.7 8.1±0.7 
4 6.3±0.3 6.7±0.4 6.1 ±0.3 7.2±0.2 7.5±0.3 8.6±0.3 
6 6.6±0.3 8.0±0.4 6.5±0.l 7.5±0.3 8.2±0.4 9.1 ±0.3 
8 7.5±0.2 8.0±0.3 7.3±0.2 8.1 ±0.4 9.0±0.7 9.2±0.4 
10 8.1 ±0.4 8.1±0.2 7.9±0.l 8.7±0.4 8.4±0.2 9.2±0.9 
12 9.1 ±0.4 9.5±0.3 7.8±0.3 8.9±0.4 9.8±0.7 10.4±0.9 
152 116 77 57 58 51 
0.96 0.89 0.94 0.95 0.81 0.84 
r
2 
= 0.93 
Protein concentration was 7.03 ± 1.44 mg/mL. 
Table 17. 23Na T, Measurements (ms) for RBC Membranes in the Presence of Varying Concentrations of Amiloride at pH 8.0. 
(Trial 1) 
[Na+]/mM 
2 
4 
6 
8 
10 
12 
K 'PP/M.1 N1(1) 
0 0.5 
32.3±4.0 34.5±3.0 
41.8± 1.0 42.7±3.0 
44.6± 1.0 39.3±2.0 
47.1±1.0 43.3±0.7 
49.3±0.5 46.0±0.4 
50. l ±0.7 47.4±0.4 
474 341 
0.97 0.98 
[Amiloride]/mM 
1.0 1.5 
39. I ±2.0 40.6±3.0 
45.3±2.0 48.9± 1.0 
46.1±1.0 51.4±1.0 
49.0±1.0 52.3±0.3 
48.2±0.4 54.3±0.6 
50.0±0.7 54.9±0.9 
188 232 
0.90 0.98 
r2 = 0.94 
Protein concentration was 7.03 ± 1.44 mg/mL. 
2.0 2.5 
43.8±2.0 49.0±4.0 
46.5±1.0 50.0± 1.0 
48.9±0.6 53.7±2.0 
49.4±7.0 53.8± 1.0 
50.8±0.6 53.9±1.0 
53.0±0.7 55.1±1.0 
155 140 
0.97 0.82 
Table 18. 23Na T1 Measurements (ms) for RBC Membranes in the Presence of Varying Concentrations of Amiloride at pH 8.0. 
(Trial 2) 
[Amiloride]/mM 
0 0.5 1.0 1.5 2.0 2.5 
2 36.8±2.0 40.4±2.0 43.1±2.0 44.4±1.0 46.0±0.9 48.3±2.0 
4 40.5±0.4 43.4± 1.0 44.8± 1.0 47.0± 1.0 47.7±0.4 50.2±2.0 
6 43.7±0.7 44.2±0.6 49.0±0.8 49.2±0.6 52.1±0.4 52.9±1.0 
8 45.9±0.1 47.5±0.5 49.1 ±0.4 49.7±0.6 54.2±0.7 53.3± 1.0 
10 47.9±0.3 48.3±0.8 49.6±0.7 51.0±0.6 53.7±0.5 55.1±0.5 
12 49.2±0.5 50.6±0.7 51.1±1.0 52.8±0.8 56.6±0.8 55.7±0.5 
K •PP/M"' 
Na(a) 290 218 144 166 185 110 
0.99 0.97 0.91 0.97 0.94 0.98 
r2 = 0.89 
Protein concentration was 7.03 ± 1.44 mg/mL. 
Table 19. 7Li T1 Measurements (s) for RBC Membranes in the Presence of Varying Concentrations of Amiloride at pH 8.0. (Trial 
1) 
[ Amiloride]/mM 
[Li]/mM 0 0.5 1.0 1.5 2.0 2.5 
2 4.8±0.5 5.7±0.2 5.7±0.4 6.3±0.5 7.1±0.6 7.8±0.5 
4 6.4±0.5 6.0±0. l 6.7±0.5 7.2±0.2 8.2±0.3 8.3±0.3 
6 6.7±0. l 7.1 ±0. l 7.9±0.4 7.8±0. l 8.9±0.l 8.9±0.2 
8 7.3±0.2 7.5±0.1 7.5±0.3 8.0±0. l 9.0±0.1 8.8±0.1 
IO 7.9±0.1 7.8±0.1 8.1 ±0.1 8.8±0.1 9.4±0.1 9.3±0.1 
12 8.4±0. l 8.2±0.1 8.8±0.2 8.8±0.1 I0.1±0.1 9.9±0.1 
163 92 90 72 80 51 
0.99 0.95 0.89 0.97 0.95 0.94 
r2 = 0.96 
Protein concentration was 7.03 ± 1.44 mg/mL. 
Table 20. 7Li T1 Measurements (s) for RBC Membranes in the Presence of Varying Concentrations of Amiloride at pH 8.0. (frial 
2) 
[Amiloride]/mM 
[Li]/mM 0 0.5 1.0 1.5 2.0 2.5 
2 5.5±0.5 6.7±0.5 6.8±0.5 8.0±0.8 7.8±0.3 8.8±0.6 
4 7.5±0.4 8.1 ±0.4 8.6±0.4 8.7±0.3 9.0±0.4 9.5±0.2 
6 8.3±0.3 9.1±0.5 8.5±0.3 10. l ±0.6 10.2±0.4 10.2±0.6 
8 9.0±0.2 9.9±0.3 9.4±0.4 9.8±0.2 10.7±0.5 10.5±0.2 
to 9.8±0.2 9.7±0.3 10.2±0.4 10.4±0.4 10.2±0.3 10.6±0.2 
12 9.9±0.3 10.8±0.2 10.3±0.5 11.2±0.4 12.4±0.4 12.2±0.2 
172 131 104 99 91 59 
0.95 0.93 0.95 0.94 0.97 0.92 
r
2 
= 0.87 
Protein concentration was 7.03 ± 1.44 mg/mL. 
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Figure 10. 23Na (panel A) and 7Li (panel B) T1 Measurements with 0 mM (solid squares), 0.5 
mM (triangles), 1.0 mM (circles), 1.5 mM (diamonds), 2.0 mM (dots), 2.5 mM (open 
squares) Amiloride. Protein concentration in RBC membrane suspensions was 7 .03 ± 1.44 
mg/mL. pH was 8.0. 
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23Na and 7Li T1 values increased. The 23Na T11,,..1 values for calculating the Na+ apparent 
binding constants at pH 7.0 and pH 8.0 were 67.1 ± 0.8 ms and 65.8 ± 0.4 ms, 
respectively. The 7Li T l(r ... , values for calculating the Li+ apparent binding constants at pH 
7.0 and pH 8.0 were 20.6 ± 0.9 s and 21.0 ± 0.9 s, respectively. The protein 
concentration in the RBC membrane suspensions was 7.03 ± 1.44 mg/mL. 
The apparent Na+ and Li+ binding constants at pH 7.0 and 8.0 were listed in Tables 
13 through 20. The actual Na+ binding constants were obtained by multiplying the apparent 
Na+ binding constants with the corresponding correction factor from the correction curve 
shown in Figure 8. Figure 11 shows the apparent Li+ binding constants and the actual Na+ 
binding constants at pH 7.0 and 8.0. At pH values of 7.0 and 8.0, both Na+ and Li+ binding 
constants decreased when amiloride concentration was increased. Both Na+ and Li+ binding 
constants were higher at pH 8.0 than at pH 7.0. 
Table 21 shows the amiloride binding constants to RBC membranes with Na+ or Li+ 
present at pH 7.0 and 8.0. The amiloride binding constants in the presence of Na+ and u+ 
are higher at pH 7.0 than at pH 8.0. Statistical analysis shows that there is no significant 
difference between amiloride inhibitory binding constant to RBC membranes with Na+ and 
Li+ (1021 ± 48 vs. 964 ± 40 at pH 8.0; 731 ± 147 vs. 716 ± 27 M-1 at pH 7.0, p ~ 
0. 05). Amiloride had the same inhibitory effects on both Na+ and Li+ binding to RBC 
membranes. 
IV.S.Correlation of Na+-u+ Exchange Activity with Na+ and Li+ Binding, Phospholipid 
Composition and Total Phospholipid, and Free Mg1+ Concentration in RBCs from 
Essential Hypertensive and Normotensive Individuals 
IV .SA. Kinetic Parameters of Na+ -Li+ Exchange in Intact RBCs 
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Figure 11. Amiloride Inhibitory Activities on Na+ and Li+ Binding to RBC Membranes. 
Squares, Ki,N•<•>• pH 7.0; triangles, Ki.Na<•>• pH 8.0; dots, Ki.u. pH 7.0; diamonds, Ki.u. pH 8.0. 
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Table 21. Amiloride Inhibitory Activity on Na+ and Li+ Binding to RBC Membranes. 
pH 
7.0 
8.0 
1 2 mean± SEM 
1068 973 1021 ± 48 
878 584 731 ± 147 
1 2 mean± SEM 
1004 924 964 ± 40 
742 689 716 ± 27 
83 
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The V "'1• V mu and K,,, values of Na+ -Li+ exchange in intact RBCs from essential 
hypertensive and normotensive individuals are listed in Tables 22 and 23, respectively. As 
shown in Table 24 and in Figure 12, the rates of RBC Na+-Li+ exchange measured by the 
standard method (V ..J, and the kinetic parameters V mu and K,,, which we measured by varying 
the extracellular Na+ concentration, were significantly higher for essential hypertensive 
patients than for normotensive individuals (V 114 , V mas• and K,,, were 0.32 ± 0.09, 0.66 ± 0.17 
mrnol u•1L cell·h, and 160 ± 62 mmol/L for hypertensives vs. 0.21±0.06, 0.32 ± 0.14 
mmol u•;L cell·h, and 86 ± 69 mmol/L for normotensives, n = 10, p < 0.05). 
IV.SB. Na+ and Li+ Interactions with RBC Membranes 
Figure 13 shows the 23Na and 7Li T1 values observed upon titration with Na• (panel A) 
or u• (panel B) of unsealed membranes prepared from the RBCs of a hypertensive patient 
and those from the RBCs of a matched normotensive individual at the same membrane protein 
concentration. For the same Na+ concentrations, the 23Na T1 values were significantly higher 
(p < 0.05) for the unsealed membrane suspension from RBCs of a hypertensive patient than 
from those of the matched normotensive individual. For a given Lt concentration, however, 
the 7Li T 1 values were not significantly different (p > 0.05) for the patient and the matched 
normotensive individual. Similar results were obtained for the rest of the matched pairs. 
Na+ and Li+ binding constants to the RBC membranes from ten essential hypertensive 
and ten normotensive individuals are listed in Tables 22 and 23. Ki,,N•) values were observed 
Y values corrected by multiplying the corresponding correction factors from the curve in 
~~Na) 
Figure 8. One-way ANOV A with Tukey's conservative correction showed that Na+ binding 
constants to RBC membranes from hypertensives were significantly lower than those from 
normotensives (317 ± 85 M"' vs. 465 ± 112 M·', n = 10, p < 0.005) (Table 24 and Figure 
Table 22. Na+ -Li+ Exchange Rates (in mmol Li+ /L RBCs x h), Na+ Dissociation Constants (mM) to Outside Sites of RBCs and Na+, 
u+ Binding Constants (M.1) to RBC membranes, Phospholipid Compositions (%) and Total Phospholipid (mg/100 mg tp"), Free 
MgH Concentrations (µM) in RBC of Essential Hypertensive Patients. 
Patients v."1 vmax PC PI PS Sph PE 
42/W/F 0.29 0.54 241 193 264 31.8 1.3 15.5 21.5 29.9 49 237 
63/W/F 0.41 0.88 174 436 248 29.5 2.3 15.4 22.6 30.3 44 194 
56/W/F 0.21 0.64 258 231 250 28.2 2.3 16.7 24.6 28.2 71 210 
76/W/F 0.33 0.80 176 262 248 31.1 2.3 15.2 22.7 28.6 84 264 
72/W/M 0.46 0.63 67 267 144 30.1 3.0 16.0 25.1 25.8 84 167 
69/W/F 0.26 0.66 204 246 186 32.2 2.7 14.6 22.l 28.3 93 232 
49/W/M 0.29 0.48 81 405 196 30.0 2.0 16.2 21.6 30.2 69 194 
57/W/M 0.29 0.84 172 411 225 28.8 2.5 15.6 23.6 29.5 59 198 
81/W/F 0.46 0.81 127 310 324 30.3 2.1 14.0 22.7 31.0 63 192 
56/W/F 0.19 0.30 100 402 196 29.4 2.1 13.9 22.9 31.7 61 200 
'tp refers to total protein. "TP refers to total phospholipid. 
00 
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Table 23. Na+ -Li+ Exchange Rates (in mmol Li+ /L RBCs x h), Na+ Dissociation Constants (mM) to Outside Sites of RBCs and Na+, 
u+ Binding Constants (M- 1) to RBC membranes, Phospholipid Composition(%) and Total Phospholipid (mg/100 mg tp"), Free Mgl+ 
Concentrations (µM) in RBC of Matched Normotensive Individuals. 
Controls V.14 vmu PC PI PS Sph PE 
31/W/F 0.28 0.50 94 703 232 29.1 2.5 14.2 21.2 33.0 68 254 
47/W/F 0.10 0.14 119 473 228 24.8 1.9 15.4 24.9 33.0 45 161 
41/W/F 0.14 0.16 31 490 299 28.1 1.3 14.5 21.5 34.7 68 233 
53/W/F 0.22 0.36 39 498 308 31.3 1.2 12.1 21.7 33.7 67 298 
50/W/M 0.18 0.25 99 400 165 26.2 1.6 14.7 24.4 33.1 26 237 
52/W/F 0.17 0.28 81 358 242 28.2 2.3 12.9 25.9 30.8 23 215 
30/W/M 0.31 0.43 54 256 189 28.7 2.0 13.0 21.8 34.5 80 254 
32/W/M 0.25 0.28 45 465 230 32.8 1.8 11.7 25.3 28.4 67 276 
65/W/F 0.24 0.60 272 452 214 28.1 1.5 14.0 23.9 32.5 52 222 
46/W/F 0.18 0.21 22 553 219 29.5 1.9 15.9 21.9 30.8 65 259 
•tp refers to total protein. "TP refers to total phospholipid. 
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Table 24. Na+-u+ Exchange Parameters, Na+ and Li+ Binding Constants, Phospholipid 
Composition and Total Phospholipid, and Free Mgl+ Concentration in RBCs and Clinical 
Characteristics of Essential Hypertensive and Nonnotensive Individuals. 
N onnotensives Hypertensives p 
(n = 10) (n = 10) 
V 114, mmol/L cell· h 0.21±0.06 0.32±0.09 < 0.01 
V -x• mmol/L cell· h 0.32±0.14 0.66±0.17 < 0.001 
K,,,, mmol/L 86±69 160±62 < 0.05 
~Na)' M·l 465±112 317±85 < 0.005 
~1· M'' 233±41 228±48 > 0.05 
PC" 28.7±2.2 30.1 ±1.2 > 0.05 
PI" 1.8±0.40 2.3±0.40 > 0.05 
PS" 13.8± 1.3 15.3±0.9 < 0.05 
Sph" 23.3± 1.7 22.9± 1.1 > 0.05 
PE" 32.5±1.8 29.4±1.6 < 0.001 
Total phospholipid, mg/ 100 mg tpb 56±18 68±15 > 0.05 
[Mg2+]r, µM 241 ±36 209±27 < 0.05 
Triglycerides, mg/dL 158±70 174±71 > 0.05 
Cholesterol, mg/dL 203±28 225±43 > 0.05 
Diastolic pressure, mm Hg 75±4 83±10 < 0.05 
Systolic pressure, mm Hg 121±9 139± 16 < 0.01 
Age, y 45±10 62±12 < 0.05 
Values are mean±SEM. Statistical analysis performed with one-way ANOVA with Tukey's 
conservative correction. p ~ .05 was considered significantly different. 
"Percentage of total phospholipid. btotal protein. 
88 
Figure 12. Kinetic Parameters of Na+ -Li+ Exchange in Intact RBCs from Ten Essential 
Hypertensive (circles) and Ten Normotensive (squares) Individuals. (A) and (B), Na+ -Li+ 
exchange rates, V "4 and V mas• respectively; (C), affinity constants of Na+ -Li+ exchange in 
RBCs, K,,,. 
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Figure 13. 23Na (A) and 7Li (B) T1 Measurements in the RBC Membrane Suspensions from 
An Essential Hypertensive (circles) and the Matched Normotensive (squares) Individual. 
91 
55 A 
50 
45 
tn 
E 
....... 
40 
"I"'" 
..... 35 
30 
25 
0 2 4 6 8 10 12 
[Na+] I mM 
8 B 
7 
6 
tn 
....... 5 
"I"'" 
..... 
4 
3 
2 
0 2 4 6 8 10 12 
[Li+] I mM 
92 
14), indicating that Na+ was bound to the RBC membranes from hypertensives more weakly 
than from normotensives. No significant difference was found between the two groups for 
the Li+ binding constants to RBC membranes (Table 24 and Figure 14). 
IV .SC. Phospholipid Composition and Total Phospholipid 
Figure 15 shows a typical lip NMR spectrum of a phospholipid extract from the RBC 
membranes from an essential hypertensive patient. The assignments of the phospholipid 
resonances are indicated in the spectrum and were obtained as described in Methods .. Two 
types of PE are present in human RBC membranes, and they can be discriminated by lip 
NMR spectroscopy: regular PE has an alkyl ether on the glyceride backbone, whereas PE 
plasmalogen has an alkenyl ether. The areas under the two PE resonances were added to 
yield the PE composition. 
The values of phospholipid compositions and total phospholipid in the RBC membranes 
from ten essential hypertensive and normotensive individuals are listed in Tables 22 and 23. 
Table 24 and Figure 16 show that the percentage of PS in RBC membranes was significantly 
higher for essential hypertensive patients than for normotensive individuals (15.3 ± 0.9% vs. 
13.8 ± 1.3 % , n = 10, p < 0.05), whereas the percentage of PE was significantly lower 
(29.4 + 1.6% vs. 32.5 ± 1.8%, n = 10, p < 0.001). No statistically significant differences 
(p ~ 0.05) were found between the patient and control groups for the percentages of the 
other phospholipids. 
The total phospholipid concentrations in the RBC membranes from hypertensive patients 
and normotensive individuals were also measured by the lip NMR method; there was no 
statistically significant difference between the RBC membranes of the two groups in their total 
phospholipid concentrations (Table 24). 
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Figure 14. Na+ (A) and Li+ (B) Binding Constants to the RBC Membranes from Ten 
Essential Hypertensive (circles) and Ten Normotensive (squares) Individuals. 
94 
U) 
... 
c IJ ca c c 
... D d DCC U) 
c 
0 
0 
C> 
c 
·-
-cs 
c 
·- 0 0 m 0 0 ) 0 0 
+ 0 0 
·-
0 
...J 
<( 
U) D 
...., D c D~ p D D c c 
ca 
... 
U) 
c 
0 
0 
C> 
c 
·- 0 0 
-cs 0 0 p 0 0 0 
c 0 0 
·-m 
+ 
ca 
z 
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 
lO 0 lO 0 lO 0 lO 0 lO 0 lO 0 lO 0 lO 
........ ........ co co lO lO 'V 'V ("') ("') C\I C\I -r- -r-
q 
~-IN I >t 
95 
Figure 15. 31P NMR Spectrum of the Phospholipid Extracts from the RBC Membranes from 
An Essential Hypertensive Individual. The solvent mixture ratio of chloroform/methonal/0.2 
mM EDTA was 125:8:3. The assignments of each resonance are: PEp, PE plasmalogen; PE, 
phosphatidyl ethanolamine; Sph, sphingomyelin; PS, phosphatidyl serine; Pl, phosphatidyl 
inositol; AAPC, alkylacyl PC; PC, phosphatidyl choline. The positions of the resonances 
(chemical shifts) are reported relative to that of PC set at -0.84 ppm (parts per million). 
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Figure 16. Phospholipid Composition of the RBC Membranes from Ten Essential 
Hypertensive (circles) and Ten Normotensive (squares) Individuals. 
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IV .SD. Free MC+ Concentrations in RBCs 
Free Mg2+ concentrations in the RBCs from ten essential hypertensive and ten 
nonnotensive individuals were measured by 31P NMR and are listed in Tables 22 and 23. 
One-way ANOVA with Tukey's conservative correction showed that free Mg2+ concentration 
was significantly lower for the hypertensive group than for the nonnotensive group (Table 
24). 
IV.SE. Demouaphy and Clinical Characteristics 
Demography of ten essential hypertensive and ten normotensive individuals are listed 
in Tables 25 and 26, respectively. Clinical characteristics, triglyceride and cholesterol levels, 
blood pressure values for these hypertensive and normotensive individuals were obtained from 
the Hypertension Section, Loyola University Medical Center and are listed in Tables 25 and 
26, respectively. One-way ANOVA did not show significant differences between 
hypertensive and normotensive groups for triglycerides and cholesterol levels (Table 24). 
Both diastolic and systolic blood pressures are significantly higher for the hypertensive group 
than for the normotensive group (Table 24). The average value of age for the hypertensive 
group was significantly higher than for the normotensive group (Table 24). 
IV.SF. Power Analysis of Sample Size 
Power analysis of the sample size which needed in this clinical study is listed in Table 
27. A sample size of ten for each group was sufficient to yield statistically significant 
differences with a power level of 0.90, and an a value of 0.05, for all of the RBC parameters 
(V ltd• V mu.• Ka,, Ki,,N•>' PS, and PE) which were also statistically significantly different by one-
way ANOVA with Tukey's conservative correction. For a power level of 0.95, however, 
Table 25. Demography of Essential Hypertensive Patients. 
Patients Age Race Sex Weight BP(S/D) Smoker Triglycerides Cholesterol 
(y) (LBs) (mm Hg) (mg/dL) (mg/dL) 
l 42 w F 157 110170 N 68 250 
2 63 w F 154 144/94 N 136 333 
3 56 w F 218 130/92 N 188 212 
4 76 w F 162 150/90 N 154 254 
5 72 w M 234 160/90 N 238 178 
6 69 w F 165 130/62 N 153 205 
7 49 w M 175 120/80 N 119 179 
8 51 w M 164 138/80 N 153 205 
9 81 w F 171 160/80 N 343 218 
10 56 w F 223 150/90 N 188 212 
BP(S/D), blood pressure (systolic/diastolic); W, white; M, male; F, female; N, no 
-8 
Table 26. Demography of Normotensive Controls. 
Controls Age Race Sex Weight BP(S/D) Smoker Triglycerides Cholesterol 
(y) (LBs) (mm Hg) (mg/dL) (mg/dL) 
31 w F 165 120/80 N 104 196 
2 47 w F 140 138/80 N 96 203 
3 41 w F 160 120/80 N 112 158 
4 53 w F 195 132176 N 349 250 
5 50 w M 170 112170 N 130 210 
6 52 w F 133 110170 N 133 202 
7 30 w M 225 122178 N 165 242 
8 32 w M 195 124/72 N 191 164 
9 65 w F 143 120178 N 130 215 
10 46 w F 129 110170 N 174 188 
BP(S/D), blood pressure (systolic/diastolic); W, white; M, male; F, female; N, no 
-0 
-
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Table 27. Sample Size for Analysis of the Kinetic Parameters of Na• -Li• Exchange in Intact 
RBCs, Na• and u• Binding Constants to RBC Membranes, Phospholipid Compositions and 
Total Phospholipid in RBC Membranes, and Free Mg2• Concentration in the RBCs Between 
Essential Hypertensive and Normotensive Groups. 
Parameters n" (0.90)b n" (0.95t 
v.,,. 10 15 
V_. 5 6 
K,,, 6 8 
~.) 10 14 
~ 1675 2452 
PC 33 48 
PI 14 21 
PS 10 17 
Sph 275 403 
PE 7 10 
Total Phospholipid 41 59 
[Mg2•1, 20 30 
Triglycerides 406 594 
Cholesterol 58 84 
Diastolic blood pressure 22 32 
Systolic blood pressure 10 15 
All samples were analyzed with an a value of 0.05. "Sample size; bpower level 
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only V -x• K,,,, and PE values were sufficient to yield statistically significant differences 
between the two groups with a value of 0.05 for a. 
IV .SG. Correlation Analysis 
For the patient group, Spearman correlation showed that the V -a values were positively 
correlated with the V 114 values (r = 0.49, p = 0.03), that K,,.N•> values were negatively 
correlated with the K,,, values (r = -0. 61, p = 0. 01), that the ~·> values were positively 
correlated with the PE values (r = 0.52, p = 0.02), and that free Mg2+ concentrations were 
negatively correlated with the V,14 (r = -0.55, p = 0.01), negatively correlated with K,,, 
values (r = -0. 76, p = 0.01) and positively correlated with the K,,.N•> values (r = 0.59, p = 
0.01). For the control group, Spearman correlation showed that the v _x values were 
positively correlated with the V,14 values (r = 0.82, p = 0.01), that the Ki,<N•> values were 
negatively correlated with the Km values (r = -0.43, p = 0.04), that the K,,.N•> values were 
positively correlated with the PE values (r = 0.42, p = 0.04) and that free Mg2+ 
concentrations were negatively correlated with V,14 values (r = -0.58, p = 0.01), negatively 
correlated with K,,, values (r = -0.63, p = 0.01) and positively correlated with ~N•> (r = 
0.40, p = 0.05) (Tables 28 and 29). 
Table 28. Spearman Correlation of Na+-u+ Exchange Parameters with Na+ and u+ Binding, Phospholipid Composition and Total 
Phospholipid, and Free Mg2+ concentration in RBCs from Essential Hypertensive Patients.* 
VlllJ vmH K... Kb( Na) Kb(U) PC PI PS Sph PE TP [Mg2+), 
v 11/J 1.00 
vmn 0.49 1.00 
(0.03) 
K... 0.38 0.24 1.00 
Kb(Na) 0.24 0.35 -0.61 1.00 
(0.01) 
Kb<U> 0.16 0.32 0.05 -0.22 1.00 
PC 0.30 -0.04 0.14 -0.47 -0.02 1.00 
(0.03) 
PI 0.17 0.42 -0.06 0.06 -0.56 -0.05 1.00 
(0.05) (0.01) 
PS 0.01 -0.10 0.07 -0.00 -0.07 -0.39 0.11 1.00 
Sph 0.05 0.11 -0.24 0.00 -0.21 -0.60 0.60 0.20 1.00 
(0.01) (0.01) 
PE -0.03 -0.04 -0.27 0.52 0.33 -0.10 -0.68 -0.58 -0.39 1.00 
(0.02) (0.01) (0.02) 
TP -0.05 -0.18 -0.02 -0.45 -0.47 0.35 0.51 0.07 0.24 -0.66 1.00 
(0.04) (0.03) (0.03) (0.01) 
[Mg2+), 
-0.55 -0.12 -0.76 0.59 0.21 0.30 -0.17 -0.15 -0.34 -0.17 0.14 1.00 
(0.01) (0.01) (0.01) 
*Correlation coefficients ~ 0.40 are considered significant (p s; 0.05). Values in parentheses are p values for significance. 
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Table 29. Spearman Correlation of Na+ -Li+ Exchange Parameters with Na+ and Li+ Binding, Phospholipid Composition and Total 
Phospholipid, and Free Mg2+ concentration in RBCs from Normotensive Individuals.• 
V,14 vmu ~ Kb(Na) Kb< LI> PC PI PS Sph PE TP [Mg2+lr 
V,14 1.00 
vm .. 0.82 1.00 
(0.01) 
Km 0.02 0.30 1.00 
Kb(Na) -0. 08 -0.13 -0.43 1.00 
(0.04) 
Kb(u1 -0.26 -0.09 -0.34 0.34 1.00 
PC 0.37 0.35 0.37 -0.48 0.37 1.00 
(0.03) 
PI 0.24 0.14 0.19 -0.10 -0.18 0.04 1.00 
PS 0.03 0.05 0.08 0.31 -0.38 -0.57 0.10 1.00 
(0.02) 
Sph -0.31 -0.26 0.32 -0.58 -0.25 -0.18 0.15 -0.16 1.00 
(0.02) 
PE -0.04 -0.06 -0.10 0.42 0.08 -0.33 -0.34 0.14 -0.65 1.00 
(0.04) (0.01) 
TP 0.58 0.29 -0.45 0.29 0.18 0.44 -0.01 -0.20 -0.76 0.48 l.00 
(0.02) (0.04) (0.04) (0.01) 
[Mg2+lr -0.58 0.26 -0.63 0.40 0.16 0.87 -0.21 -0.37 -0.37 -0.02 0.52 l.00 
(0.02) (0.01) (0.05) (0.01) (0.01) 
*Correlation coefficients ~ 0.40 are considered significant (p ~ 0.05). Values in parentheses are p values for significance. 
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CHAPTER V 
DISCUSSION 
V .1. Na• -Li• Exchange Activity in Intact Human RBCs with and without Inhibitors 
The osmolarity inside normal red blood cells is 290 miliosmoles/L. To maintain the 
cells intact in the process of the experiments, the osmolarities in the media have to be 
maintained at 300 ± 10 miliosmoles/L. Therefore the highest Na+ concentration in the media 
that can be reached is 150 mM. Before 1990, the maximal rates of Na+ -Lt exchange in 
human RBCs were generally assayed by subtraction of the Li+ efflux rates of Li+ -loaded 
RBCs in Na+ -free medium from the rates in 150 mM NaCl medium (Canessa et al., 1980a). 
Mechanistic studies of RBC Na+ -Li+ exchange have indicated that the RBC membrane 
transport protein is asymmetric, with higher Na+ and Li+ affinities on the intracellular than 
on the extracellular side of the membrane (Hannert et al., 1986; Sarkadi et al., 1978). It was 
recently found that, under standard transport assay conditions, Li+ is present at a saturating 
concentration at the internal binding site of the RBC membrane transport protein, but Na+ 
may not be saturating at the external site (Rutherford et al., 1990; Rutherford et al., 1992a). 
The dissociation constants (K,,.) for extracellular Na+ are, at least for some individuals, of the 
same order of magnitude as the extracellular Na+ concentration (140 mmol/L) used in the 
standard transport assay, suggesting that the RBC Na+-u+ exchange protein is far from 
saturated with Na+ on the extracellular side of the RBC membrane. The rates under standard 
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transport assay conditions may not, therefore, be maximal rates of RBC Na+ -Li+ exchange; 
variations in Na• affinity (K,,,) and maximal velocity (V_J could change the observed rates. 
Only by varying the Na• concentration in an isotonic suspension medium can one measure 
the true kinetic parameters of RBC Na• -Li+ exchange (Aronson, 1990; Rutherford et al., 
1990; Rutherford et al., 1992a). 
It was reported that amiloride had no effect on Na+ -Li+ exchange in human intact 
RBCs (Carr et al., 1988; Kahn, 1987). However, the inhibitory effects of amiloride and its 
analogues were reported only on the standard rates of Na+ -Li+ exchange. To our knowledge, 
there have been no reports about the effects on V mu and ~· In this study we found that 
amiloride significantly decreased V mu and HMA had significant effects on both Vmn and ~ 
(Tables 1 and 2). HMA had higher inhibitory effects than did amiloride. This is in 
agreement with the previous reports (Kleyman & Cragoe, 1988; Simchowitz & Cragoe, 
1986). Amiloride and its analogues are specific Na+ -H• exchange inhibitors. They 
specifically bind to the Na ·-H• transport protein and decrease the exchange rates. Table 1 
shows that they have significant effects on Na+ -Li• exchange. Gende et al found that EIPA 
blocked the exchanges of Li ... or Na+ with H ... (Gende & Cingolani, 1993). They also found 
that thrombin, an activator of Na•-H+, could stimulate u• as well as Na+ exchange (Gende 
& Cingolani, 1993). All of these results suggest that the Na+ -Lt exchange protein is highly 
likely the same as the Na• -H ... exchange protein. 
V .2. Li+ Emux Across H+ - and u• -loaded Resealed RBC Ghosts 
Resealed RBC ghosts are devoid of hemoglobin, which is the major nonmembrane 
protein in the cells, and other factors. Measurements of Li ... movements across resealed RBC 
ghosts, instead of through intact RBCs, simplify the study of RBC transport proteins. If Na+ -
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H+ and Na+ -Li+ exchange are mediated by the same transport protein, they will compete with 
each other for interaction with the same membrane transport protein. The pH value inside 
the resealed RBC ghosts was 6.0. When H+ - and Li+ -loaded resealed RBC ghosts were 
suspended in the NaCl media with a higher pH value (8.0), H+ came out of the ghosts. Li+ 
efflux rates were significantly lower when H+ efflux occurred simultaneously with and 
without the inhibitors (Figure 7 and Table 3). This means that H+ and u+ competed to bind 
to the same membrane protein to be transported out of the ghosts. Previous studies on 
interactions of lithium and protons with the sodium-proton exchanger in intact RBCs indicated 
that lithium behaved same as protons (Parker, 1986). Both of them can stimulate Na+ -H+ 
exchange when they are enriched inside of the cells and can inhibit Na+ -H+ when they are 
enriched outside of the cells (Parker, 1986). 
Phloretin significantly decreased the Li+ efflux rates no matter if there was a pH 
gradient or not (Figure 7 and Table 3), which is predictable according to the previous work 
(Pandey et al., 1978). HMA, which is a specific Na+ -H+ exchange inhibitor, also 
significantly inhibited the Li+ efflux across the resealed RBC ghosts. This result is in 
agreement with the inhibitory effect of HMA on Na+ -Li+ exchange in the intact RBCs, and 
furthermore proves that Na+ -Li+ exchange and Na+ -H + exchange are mediated by the same 
membrane protein. 
Using resealed RBC ghosts, one can avoid the interferences of hemoglobin and load 
the required concentrations of ions. But the membrane constituents might change during the 
preparation, especially in the course of hemolysis. Although no lipids are lost during the 
preparation of the resealed ghosts, a considerable structural change can occur (Schwoch & 
Passow, 1973). The fluidity of the phospholipid bilayer also changed. Some enzymes and 
enzyme activities might be lost during the preparation. Keeping the osmolarity in the range 
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of 60 -80 miliosmoles/L can retain most of the enzymes and the enzyme activities (Schwoch 
& Passow, 1973). Ionic strength and pH affect the loss of membrane proteins and their 
structures (Bodemann & Passow, 1972; Schwoch & Passow, 1973). In order to remove most 
of the hemoglobin and keep the membranes resealable, the temperature must be maintained 
at 0 - 2 °C during hemolysis. However, resealed RBC ghosts still contain primary cell 
membranes and maintain most of the characteristics of the native erythrocyte membranes 
(Klonk & Deuticke, 1992). The data above on u+ efflux across the resealed RBC ghosts still 
provide strong evidence that Na+-H+ exchange and Na+-u+ exchange are mediated by the 
same membrane protein. 
V.3. Na+ Visibility in RBC Membranes and the Correction Curve 
In the intact RBCs the Na+ visibility is only 75% (Nissen et al., 1989). In the RBC 
membrane suspensions the visibility varied as Na+ concentration changed (Table 4). The 
lower the Na+ concentration, the lower the visibility. Sodium is a quadrupolar nucleus with 
a spin of 3/2, which is not under conditions of extreme narrowing (Bull, 1972). When 
sodium ions were exposed to the RBC membrane suspensions, the ions experienced two states 
of motion. In other words, they experienced a two-site exchange. One site is the hydrated 
ion in aqueous solution which is under the extreme narrowing condition and is called the 
narrow component, and the other site is the membranous peptide binding site which is not 
under the extreme narrowing condition and is called the broad component. The spin-lattice 
relaxation time (1'1) is the sum of the relaxation time of these two components (Bull, 1972; 
Urry e tal., 1989). When the broad components are too broad, they are hardly visible by 
NMR (Urry e tal., 1989). The NMR-invisible Na+ is due to the broad components, i.e., the 
bound Na+. Increased T, values following the additions of 150 mM Li Cl confirmed the 
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release of the bound sodium (Table 4). And after the bound sodium was released by lithium, 
sodium was about 100% visible. 
Actual Na+ binding constants were addressed by the experiments shown in Tables 5 to 
9. We generated the correction curve in the Kb<N•> range of 150 - 260 M·1• At lower binding 
constants, the correction factors were close to 1.00, and the actual Na+ binding constants 
were close to the observed Na+ binding constants; the interactions between Na+ and the 
membranes were weak at the lower binding constants and there were more free sodium. For 
larger binding constants, however, the correction factors were significantly higher than 1.0 
because of the larger fraction of invisible bound Na+. The time-consuming processing of the 
experiments prevented us to get a correction curve in a wider range. In order to get a more 
accurate curve, more points will be needed. 
V.4. Inhibitory Activities of Amiloride and Its Analogues on Na• and u+ Interactions 
with RBC Membranes 
As mentioned before, amiloride is a specific Na+-H+ exchange inhibitor. It is a weak 
base (pK. = 8. 7) (Kleyman & Cragoe, 1988). In the 1960's, many amiloride analogues were 
synthesized. And in the 1980's, a lot of work on the inhibitory effects of amiloride analogues 
on Na+-H+ exchange in the intact RBCs has been done (Kleyman & Cragoe, 1988; 
Simchowitz & Cragoe, 1986; Vigne et al., 1983). Studies on structure-activity relationships 
of amiloride analogues indicated that the guanidinium moiety of amiloride is the active group 
that recognizes and binds to the Na+ transport site of the exchanger (Simchowitz & Cragoe, 
1986). Increasing the number of carbon atoms in the alkyl chain at the 5-N position 
increased the activity (Simchowitz & Cragoe, 1986). The inhibitory activity can be 
demonstrated by the apparent K1 value which is the dissociation constant. The lower the 
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apparent K1, the higher the activity. For Na+ -H+ exchange in the intact RBCs, the apparent 
K1 values of amiloride, HMA, EIPA and MIA are 83.8 µM, 0.16 µM, 0.38 µM and 0.44 
µM, respectively (Kleyman & Cragoe, 1988; Simchowitz & Cragoe, 1986). In this study we 
measured both 23Na and 7Li T1 values with varying concentrations of these inhibitors (Tables 
11 and 12, Figure 9). All of these inhibitors inhibited the interaction of Na+ with the 
membranes, which is in agreement with a recent report (Spruth et al., 1995). Spruth et al. 
found that the amiloride derivatives and Na+ compete for a common binding site (Spruth et 
al., 1995). Meanwhile, we also found that all of these inhibitors inhibited the interaction of 
Li+ with the membranes. The inhibitory effects of these inhibitors were of the same order 
of magnitude, though HMA has the highest effects. Therefore we chose amiloride to address 
its inhibitory constants to RBC membranes for Na+ and Li+ binding to RBC membranes. The 
inhibitory activities of amiloride and its analogues relate to the biological system. Senyk et 
al. reported that the inhibitory constants for amiloride and EIPA are 8 µM and 1 µM, 
respectively, in rabbit alveolar type-II Na+ channels reconstituted in planar lipid bilayers 
(Senyk et al., 1995). The inhibitory effects of amiloride and EIP A are of the same order of 
magnitude in these reconstituted Na+ channels. 
The 23Na or 7Li T 1 values increased as Na+ or Li+ concentration increased in RBC 
membrane suspensions at specific amiloride concentrations (Tables 13 to 20 and Figure 10) 
because there were more free Na+ or Li+ as the Na+ or Li+ concentration increased. At the 
same Na+ or Lr concentrations, the 23Na or 7Li T1 values increased as the amiloride 
concentration increased. This indicated that amiloride inhibited both Na+ and Li+ binding to 
the RBC membranes and left more free Na+ or Li .. , resulting in weaker Na+ and Lr binding 
to the membranes. Therefore both Na+ and Li+ binding constants decreased as the amiloride 
concentration increased at pH values of 7.0 and 8.0 (Tables 13 to 20 and Figure 11). 
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Both Na+ and Li+ binding constants were higher at pH 8.0 than at pH 7.0 (Tables 13 
to 20 and Figure 11), because H + competed with both Na+ and Li+ for binding to the RBC 
membranes. Another reason is that the inhibitory effect of amiloride is higher at pH 7.0 than 
at pH 8.0. Amiloride is a weak base and only the protonated form of amiloride can interact 
with the membrane protein (Kleyman & Cragoe, 1988). Therefore, the lower the pH, the 
higher the inhibitory activity. For the same reason, amiloride binding constants to RBC 
membranes were higher at pH 7.0 than at pH 8.0. The most important thing is that there is 
no significant difference between amiloride binding constants to RBC membranes with Na+ 
and Li+ present. Amiloride had the similar inhibitory effects on both Na+ and Li+ binding 
to RBC membranes. The inhibitor studies proved that Na+-u+ and Na+ -H+ exchange are 
mediated by the same RBC membrane protein. 
The amiloride binding constants to the exposed RBC membranes at pH 7.0 and 8.0 are 
much lower than the reciprocal of the amiloride apparent K1 for Na+ -H+ exchange in intact 
RBCs. There are several reasons which can explain this difference. Amiloride had high 
blockage effect when it was applied to the outside face of the membranes, but had no effect 
when it was applied to the inside face (Small & Morris, 1995). When amiloride was applied 
to both sides of the membranes, the inhibitory effect must be lower than the effect when it 
was applied to only the outside of the membranes. Although RBC membranes still maintain 
the characteristics of the native erythrocyte membranes, Na+-H+ and Na+-u+ exchange 
proteins might change in the amount and in the structure after lysed from intact RBCs 
(Bodemann & Passow, 1972; Schwoch & Passow, 1973). The distribution, the amount, and 
the structure of the protein in the exposed membranes might be different from that in intact 
RBCs. Amiloride inhibitory activity also varies from one isoform to another isoform of the 
Na+ -H+ exchanger. For instance, the 50% inhibition concentration values for amiloride and 
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EIP A of the NHE mutant are significantly higher than that of the wild type NHE 1 (Wang et 
al., 1995). 
V.5. Correlation of Na+-Li+ Exchange Parameters with Na+ and Li+ Binding, 
Phospholipid Composition and Total Phospholipid, and Free Mg1+ Concentration 
in RBCs from Essential Hypertensive and Normotensive Individuals 
The AA-determined rates of RBC Na+-u+ exchange measured under standard assay 
conditions (V wJ and in isotonic media containing varying Na+ concentrations (V _J were 
found to be significantly higher for the hypertensive patients than for the normotensive 
individuals (Tables 22 to 24 and Figure 12); the exchange rates for female were, however, 
not significantly lower (p > 0.09) than for male individuals in both the patient and control 
groups. The gender variations and the enhanced rates that we observed for the hypertensive 
patients are not in agreement with those previously reported, presumably because of the small 
sample size used in our study (Canessa et al., 1980a; Laurenzi and Trevisan , 1989; 
Ramasamy et al., 1990; Rutherford et al., 1990). Within the patient group, one-way 
ANOV A analysis did not show significant difference for the AA-determined V std and v _x 
values of RBC Na+ -Li+ exchange between the subgroup that was taking antihypertensive 
medication and the subgroup that was not taking any medication; these results are in 
agreement with those previously reported (Canessa, 1980b; Ramasamy et al., 1990), which 
show that medications for the regulation of blood pressure do not affect the enhanced rates 
of RBC Na+-Li+ exchange in hypertensive patients. A recent study (De la Sierra et al., 
1995) that appeared in print after we collected the blood samples for this study, however, 
showed that long-term antihypertensive therapy with angiotensin-converting enzyme inhibitors 
(ACEI) caused a significant decrease in the rates of RBC Na+ -Li+ exchange. Three of the 
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ten patients used in our study were receiving ACEI therapy. However, we found no 
significant differences (p > 0.23) in the V 114 and V mu values between these three and the 
remaining seven patients; this difference between our study and that on the effect of ACEI 
therapy on RBC Na+ transport (De la Sierra et al., 1995) might be related to the smaller 
sample size used in our study. The AA-determined dissociation constants of Na+ to the 
extracellular side of RBC membranes (K,..) were also significantly higher for hypertensive 
patients than for normotensive individuals (Tables 22 to 24 and Figure 12); the K,,, values that 
we obtained for RBCs from both hypertensive patients and normotensive individuals are in 
general agreement with those previously measured in some other investigations (Canessa et 
al., 1992; Rutherford et al., 1992b) but not in all previous reports (Rutherford et al., 1990). 
The authors of some recent studies (Canessa et al., 1992; Zerbini et al., 1995) have 
claimed that ~ values in the range of 160 mmol/L for RBC samples from hypertensive 
patients cannot be obtained accurately from measurements at an extracellular Na+ 
concentration of 150 mmol/L. This statement is true only provided that the estimates of~ 
are derived from hyperbolic Michaelis-Menten plots (as opposed to K,,, estimates originating 
from linear, double-reciprocal plots of l/v vs. l/[Na+]). In our study, however, we did not 
simply conduct single measurements in suspensions containing 150 mmol/L Na\ we varied 
the extracellular Na+ concentration from 0 to 150 mmol/L, and we maintained the isotonicity 
of all suspension media at 0.15 mol/L with choline chloride (see Methods). The method 
recently described by Canessa and co-workers (Canessa et al., 1992; Zerbini et al., 1995) 
involves the use of hypertonic Na+ media (150-250 mmol/L). We do not favor that method 
because there were no data in these two studies to support the contention that the ionic 
permeability of RBC membranes (including that mediated by Na+ -Li+ exchange) and the 
viability of the cells were not affected by the harsh, hypertonic conditions. 
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Na+ and Li• ions are in the fast exchange domain on the 23Na and 7Li NMR time scales 
(Mota de Freitas, 1993; Mota de Freitas et al., 1994a; Ong and Cheung, 1986; Urry et al., 
1980); the 23Na or 7Li T1 values (Figure 13) measured with RBC membrane samples of 
patients and normal individuals therefore depict the weighted averages of free Na+ or Li• in 
the suspension medium and of Na• or Li+ bound to the RBC membranes. Free Na+ or Li+ 
exhibits relatively larger T 1 values than does bound Na+ or Lt. The 23N a or 
7Li T 1 values 
increased in the presence of increasing concentrations (0 to 10 mmol/L) of Na+ or Li+ in 
membrane samples of both hypertensive patients and normotensive individuals because of 
increasing concentrations of free Na+ or Li+. These observations confirm that both 23N a and 
7Li T1 values are sensitive to Na+ and Lt binding to RBC membranes, and that they can be 
used for the calculation of the Na+ and Li+ binding constants to RBC membranes from James-
N oggle plots (see Methods). For Na+ concentrations lower than 10 mmol/L, the amount of 
Na+ bound to the same amount of RBC membrane was smaller for hypertensive patients than 
for normotensive individuals (Figure 13, panel A); for Na+ concentrations ;;::: 10 mmol/L, the 
amount of Na+ bound to RBC membranes from both hypertensive patients and normotensive 
individuals appears to be the same, however, because the observed 23Na T1 values are mostly 
determined by the fractions of free Na+. In contrast, for a given Li+ concentration, the 
amount of Li+ bound to the RBC membranes of hypertensive patients was not significantly 
different from that of normotensive individuals (Figure 13, panel B). Our observed 23Na T1 
data (Figure 13, panel A) and the calculated and corrected Ki,<N•> values (Figure 14 and Tables 
22 to 24) indicate that Na .. has a weaker affinity for RBC membranes of hypertensive patients 
than for those of normotensive individuals. However, our observed 7Li T1 results (Figure 13, 
panel B) and the calculated Kb<U> values (Figure 14 and Tables 22 to 24) indicate that Li+ has 
a similar affinity for RBC membranes of both hypertensive patients and normotensive 
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individuals. Our calculated and corrected ~N•> values are in agreement with those previously 
calculated from 23Na T 1 values measured in suspensions of RBC membranes from hypertensive 
patients and normotensive individuals (Ong and Cheung, 1986; Urry et al., 1980). Similarly, 
our calculated ~1..11 values for RBC membranes from normotensive individuals are in 
agreement with those found in our previous investigation of lithium-treated bipolar patients 
and normal individuals (Mota de Freitas et al., 1994a). 
The Na+ binding constants, ~N•>' that we calculated from the 23Na T 1 values measured 
in Na+ -containing suspensions of unsealed RBC membranes are measures of Na+ binding to 
the phosphate head groups of phospholipids and protein binding sites present in the internal 
and external leaflets of the RBC membrane. In contrast, the AA-determined K,,, values which 
we obtained by varying the extracellular Na+ concentration in the transport assay are Na+ 
dissociation constants to the extracellular side of the membrane Na+ -Li+ exchange protein. 
It is therefore not surprising that significant negative correlations existed between the Ki,<N•> 
values and the K,,, values within the patient and control groups. A comparison of ~N•> and 
K,,, requires taking the reciprocals of one of these sets of values; the values of Kb<N•> are larger 
than those of llK"', presumably because of the additional number of membrane binding sites 
for Na+ that are probed in the 23Na NMR relaxation measurements relative to the AA-
determined transport measurements. 
The head groups of the phospholipids PI and PS are negatively charged; these two 
anionic phospholipids reside primarily in the inner leaflet of the RBC membrane. Our 
previous 7Li NMR relaxation studies of Li+-loaded RBCs and of RBC components in the 
absence and presence of varying Mg2+ concentrations indicate that the primary binding sites 
for alkali metal ions in intact RBCs are present in the cytoplasmic side of the RBC membrane 
(Mota de Freitas et al., 1994b; Rong et al., 1993), and that variations in Li+ or Na+ binding 
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constants to RBC membranes may be associated with abnormal phospholipid composition 
(Mota de Freitas et al., 1994a). Our lip NMR data (Tables 22 to 24 and Figure 16) indicated 
that there were significant differences between the hypertensive and normotensive groups in 
the percentages of PS and PE, but not in those of PC, Sph, and PI. The phospholipid 
compositions of the human RBC membrane that we measured by 31P NMR spectroscopy are 
in general agreement with those measured by others by two-dimensional thin-layer 
chromatography (Preiss et al., 1982; Sengupta et al., 1981) or high-performance liquid 
chromatography (Kurumi et al., 1991). The slightly different percentage compositions 
measured for human RBC membranes by the different methods are attributed to the fact that 
31P NMR spectroscopy measures the total phosphate directly in each phospholipid headgroup; 
the visualization reagents used in thin-layer chromatography or the ultraviolet absorbance 
measurements in high-performance liquid chromatography result in detection of only 
unsaturated fatty acids by these methods (Pearce et al., 1991; Spillman et al., 1983). These 
methodologic differences presumably also account for the fact that we found, in this study, 
significant differences between the RBC membranes from hypertensive and normotensive 
groups in the percentage compositions of PS and PE, but no significant differences were 
found previously with thin-layer chromatographic measurements (Preisset et al., 1982). 
We also used lip NMR spectroscopy to measure the total phospholipid concentrations 
in the RBC membranes from hypertensive patients and normotensive individuals and found 
that they were not significantly different (Table 24). The total phospholipid concentrations 
in the RBC membranes that we measured by lip NMR spectroscopy were, however, in good 
agreement with those previously reported (Kurumi et al., 1991; Sengupta et al., 1981). The 
statistically significant differences that we found in the percentages of PS and PE are 
therefore not associated with variations in the total phospholipid concentrations of the RBC 
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membranes from the two groups. 
Previous np and 2H NMR studies of phospholipid suspensions indicated that PS and PI 
interacted with Li+ and Na+ ions (Merchant and Glonek, 1992; Roux. and Bloom, 1990). 
We found significant differences between the two groups for the PS values by one-way 
ANOVA with Tukey's conservative correction (Table 24). Because of baseline noise and the 
small amounts of PI present in RBC membranes (Edzes et al., 1992; Mota de Freitas, 1994a), 
it is possible only to determine the PI content with an accuracy of ±20%; the low accuracy 
of the PI content measured by the 31P NMR method indicates that differences between the two 
groups in Pl levels and any correlations between the PI content and the kinetic transport 
parameters should be interpreted with caution. The PS content in RBC membranes is, 
however, sufficiently high to be determined accurately by 31P NMR spectroscopy. We 
speculate that the higher PS percentage composition of RBC membranes from hypertensive 
patients relative to that from normotensive individuals might drive the positively charged 
extracellular Na+ ions to traverse the RBC membrane more quickly for essential hypertensives 
than for normotensives. We previously reported that Li+ -treated bipolar patients had lower 
Na+ _Li+ exchange rates, which were negatively correlated with Li+ binding to RBC 
membranes, and that they had higher PS contents than did normal individuals (Mota de 
Freitas et al., 1994a). The higher PS content in the inner leaflet of RBC membranes of 
lithium-treated bipolar patients is presumably responsible for a stronger interaction with 
intracellular Li+ and makes it more difficult for Li+ to be transported, resulting in lower rates 
of RBC Na+-Li+ exchange (Mota de Freitas et al., 1994a). 
Free intracellular magnesium concentrations were significantly lower for essential 
hypertensive patients than for normotensive individuals (Tables 22 to 24), which is in 
agreement with previous reports (Gupta and Gupta, 1987; Resnick et al., 1984). Touyz et 
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al. reported that total intracellular magnesium levels were significantly lower for hypertensives 
than for normotensives (Touyz et al., 1992). Significantly increased intracellular sodium was 
observed in the essential hypertensive group (Touyz and Milne 1995). This might be due to 
the fast transport of Na+ in essential hypertension. Magnesium appears closely linked to 
calcium, potassium and sodium balances. Gros et al recently reported that the increases in 
Na• ingest brought a significant drop in Mg2• content in gastrocnemius (Gros et al., 1995). 
In this study we found negative correlations of free magnesium levels with Na• -Li• exchange 
activities in essential hypertension. In both the essential hypertensive and the normotensive 
groups, free magnesium concentrations were negatively correlated with V ltd and K.,,, which 
follows from the above reports concerning lower free and total intracellular Mg2+, and higher 
intracellular sodium in hypertension. But to understand whether lower free intracellular 
magnesium is one of the reasons causing higher Na+ -Li• exchange activity, more detailed 
work needs to be involved; in particular, the effect of antihypertensive medication (Gupta and 
Gupta, 1987; Resnick et al., 1984) needs to be evaluated. 
In this initial, exploratory study, we did not recruit hypertensive patients or 
normotensive individuals who were on a specific diet. It is therefore possible that the 
percentages of phospholipids as well as the levels of triglycerides and of cholesterol that we 
report for RBC membranes were influenced by the type of diet that the subjects were on at 
the time of blood drawing. It is important to note, however, that all of our subjects were 
instructed to have fasted for a minimum of 12 hr at the time of blood drawing; we estimate 
that only approximately 70% of the subjects complied with these instructions. We believe 
that this precaution which we took in our experimental design should have minimized the 
contribution of individual diets on the lipid compositions of the RBC membranes that we 
measured. 
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In our study, there was a perfect match between the patient and control groups in terms 
of race and gender. Although we attempted to match each essential hypertensive patient as 
closely as possible with a normotensive patient of similar age, this was not always achieved, 
as is apparent from the significantly higher average age of the hypertensive patient group 
relative to the average age of the normotensive patients (Tables 22 to 24). It is always 
difficult to obtain a perfectly age-matched sample of hypertensive patients and normotensive 
individuals because essential hypertension is known to be far more common in the elderly 
population (Laurenzi and Trevisan, 1989). 
We found significant differences between the patient and control groups in both the 
systolic and the diastolic blood pressure values (Tables 22 to 24). None of our patients had 
isolated late-onset systolic hypertension. Every patient had diastolic hypertension, and each 
had been diagnosed to have essential hypertension for a minimum of ten years. The 
statistically significant differences between the RBC parameters of the samples from 
hypertensive patients relative to those from normotensive individuals that we found in this 
study are therefore not related to late-onset systolic hypertension, but rather to long-term 
diastolic hypertension. 
Increased sodium-lithium countertransport activity was previously reported not only in 
hypertensive patients (Canessa et al., 1980a), but also in hyperlipidemic patients (Carr et al., 
1990; Corrocher et al., 1985; Hunt et al., 1986; Rutherford et al., 1992b). Abnormal 
membrane phospholipid composition in erythrocytes from hyperlipidemic patients has been 
investigated (Engelmann et al., 1992a; Engelmann et al., 1992b; Engelmann et al.,1993). 
To avoid the possible interference of hyperlipidemia in our investigation of essential 
hypertension, we selected patients and normal individuals with normal triglyceride and 
cholesterol concentrations. The normal average values for the cholesterol and triglyceride 
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levels at the clinical laboratory of the Loyola University Medical Center were 210 mg/dL and 
less than 250 mg/dL, respectively. In the sample that we used in our study, there were three 
essential hypertensive patients and one normotensive individual who had slightly elevated 
cholesterol levels; elevated triglyceride levels were, however, found for only one 
normotensive individual. We attribute the slightly elevated cholesterol and triglyceride levels 
for some of our subjects to non-compliance with the instructions that we gave for fasting at 
the time of blood drawing (see Methods). The triglyceride and cholesterol data listed in 
Table 24 indicate, however, that there was no significant difference between the two groups 
in triglyceride and cholesterol concentrations. 
We report here the results of our statistical analysis with one-way ANOVA method with 
Tukey's conservative correction as well as the Spearman correlation coefficients. The 
ANOV A and Spearman statistical tests are appropriate for the small sample size used in our 
study (Siegel, 1956). Despite the small sample size in this study, we were able to obtain 
statistically significant differences for, and significant correlations within, several RBC 
parameters (V max• K,,,, and PE) by using one-way ANOVA with Tukey's conservative 
correction and Spearman correlation coefficients; the power analysis that we conducted (Table 
27) confirmed that the sample size which we used was sufficient to yield significant 
differences at the 95 % confidence level. Future epidemiologic studies with the methods 
described in this study should, however, include a minimum sample size of 15 to 20 to 
confirm whether the significant differences in RBC parameters (V *' Ki,<N•>• and PS) that we 
observed at a confidence level of 90% also hold for a larger sample size. For free 
intracellular magnesium concentrations, a larger sample size of 20 (Table 27) is needed to see 
if the difference between these two groups at the power level of 0.90 is significant. We did 
not attempt to use a larger sample size because our goal was to search for the RBC 
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parameters that provide the most information on the origins of elevated rates of Na+ -Li+ 
exchange in RBCs from Caucasian, essential hypertensive patients. The time-consuming 
processing of each sample kept us from investigating a much larger sample size in this initial 
study. Our focus was not on investigating the mortality, epidemiology, or treatment efficacy 
for essential hypertensive patients; the data that we accumulated are therefore not sufficient 
to allow us to draw conclusions about these aspects of essential hypertension in Caucasian 
patients. Nonetheless, the information that we report here is important and significant 
because it identified more clearly than in previous studies the molecular abnormalities at the 
level of RBC membranes for Caucasian, essential hypertensive patients who had elevated 
rates of RBC Na+ -Li+ exchange. 
Alterations of the fatty acid composition of some phospholipids in essential hypertensive 
patients have been found to cause abnormal RBC Na+ -Lt exchange activity (Duhm, 1992; 
Engelmann et al., 1991; Engelmann et al., 1992a; Engelmann et al., 1992b; Ollerenshaw et 
al., 1987). More detailed investigations of the molecular species composition of 
phospholipids may therefore help us to understand the increased Na+ -Li+ exchange activity 
in RBCs from essential hypertensive patients. 
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